293SLAM rinderpest infection, 00hr, biol_rep1 | 13541-145H4 |
186.23 | 30.19 | 64.87 |
293SLAM rinderpest infection, 00hr, biol_rep2 | 13542-145H5 |
171.77 | 31.16 | 62.52 |
293SLAM rinderpest infection, 00hr, biol_rep3 | 13543-145H6 |
178.44 | 35.11 | 61.15 |
293SLAM rinderpest infection, 06hr, biol_rep1 | 13544-145H7 |
212.69 | 24.53 | 58.42 |
293SLAM rinderpest infection, 06hr, biol_rep2 | 13545-145H8 |
215.52 | 20.92 | 57.14 |
293SLAM rinderpest infection, 06hr, biol_rep3 | 13546-145H9 |
220.75 | 30.04 | 60.08 |
293SLAM rinderpest infection, 12hr, biol_rep1 | 13547-145I1 |
357.98 | 48.15 | 77.78 |
293SLAM rinderpest infection, 12hr, biol_rep2 | 13548-145I2 |
289.21 | 32.22 | 61.52 |
293SLAM rinderpest infection, 12hr, biol_rep3 | 13549-145I3 |
230.60 | 28.42 | 57.92 |
293SLAM rinderpest infection, 24hr, biol_rep1 | 13550-145I4 |
104.33 | 16.81 | 26.66 |
293SLAM rinderpest infection, 24hr, biol_rep2 | 13551-145I5 |
75.19 | 10.51 | 26.28 |
293SLAM rinderpest infection, 24hr, biol_rep3 | 13552-145I6 |
86.60 | 10.16 | 25.21 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1 | 13625-146H7 |
112.83 | 24.66 | 28.53 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2 | 13626-146H8 |
120.88 | 29.32 | 29.02 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3 | 13627-146H9 |
129.98 | 30.52 | 30.30 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1 | 13628-146I1 |
118.20 | 19.87 | 28.17 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2 | 13629-146I2 |
115.97 | 22.28 | 31.89 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3 | 13630-146I3 |
131.19 | 24.47 | 21.93 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1 | 13631-146I4 |
133.82 | 21.86 | 29.86 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2 | 13632-146I5 |
165.94 | 31.74 | 40.17 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3 | 13633-146I6 |
134.32 | 29.54 | 29.40 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1 | 13634-146I7 |
170.21 | 36.42 | 39.19 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2 | 13635-146I8 |
123.70 | 28.18 | 28.57 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3 | 13636-146I9 |
132.01 | 24.27 | 28.15 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1 | 13637-147A1 |
145.25 | 28.89 | 29.67 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2 | 13638-147A2 |
169.97 | 28.17 | 39.56 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3 | 13639-147A3 |
187.37 | 31.32 | 37.91 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1 | 13640-147A4 |
145.93 | 25.70 | 31.59 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2 | 13641-147A5 |
162.01 | 29.72 | 30.04 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3 | 13642-147A6 |
141.33 | 30.22 | 32.57 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1 | 13643-147A7 |
172.71 | 27.42 | 35.59 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2 | 13644-147A8 |
149.27 | 24.81 | 31.65 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3 | 13645-147A9 |
162.91 | 23.64 | 35.66 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1 | 13646-147B1 |
286.17 | 46.84 | 58.06 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2 | 13647-147B2 |
165.67 | 31.04 | 30.85 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3 | 13648-147B3 |
113.63 | 26.83 | 27.98 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1 | 13649-147B4 |
161.87 | 35.56 | 32.91 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2 | 13650-147B5 |
155.75 | 29.22 | 37.48 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3 | 13651-147B6 |
210.14 | 36.46 | 40.79 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1 | 13652-147B7 |
183.17 | 29.05 | 37.21 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2 | 13653-147B8 |
153.62 | 25.64 | 27.29 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3 | 13654-147B9 |
260.29 | 35.72 | 51.68 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1 | 13655-147C1 |
211.74 | 23.41 | 31.00 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2 | 13656-147C2 |
193.36 | 30.42 | 34.97 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3 | 13657-147C3 |
240.53 | 36.54 | 45.37 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1 | 13658-147C4 |
255.91 | 35.59 | 46.53 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2 | 13659-147C5 |
195.28 | 23.03 | 33.83 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3 | 13660-147C6 |
276.59 | 36.66 | 51.86 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1 | 13661-147C7 |
210.41 | 27.77 | 34.47 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2 | 13662-147C8 |
229.29 | 29.93 | 35.79 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3 | 13663-147C9 |
255.99 | 33.00 | 32.59 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1 | 13664-147D1 |
212.15 | 23.35 | 36.02 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2 | 13665-147D2 |
377.79 | 125.93 | 69.96 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3 | 13666-147D3 |
117.46 | 13.48 | 24.84 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1 | 13667-147D4 |
143.49 | 15.58 | 29.49 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2 | 13668-147D5 |
421.99 | 117.45 | 154.36 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3 | 13669-147D6 |
416.07 | 61.08 | 73.48 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1 | 13670-147D7 |
141.31 | 12.64 | 23.66 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2 | 13671-147D8 |
111.12 | 13.81 | 14.77 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3 | 13672-147D9 |
295.47 | 45.89 | 54.06 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2 | 13674-147E2 |
106.46 | 10.58 | 17.63 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3 | 13675-147E3 |
121.13 | 7.85 | 20.75 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1 | 13676-147E4 |
242.03 | 57.32 | 65.28 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2 | 13677-147E5 |
257.20 | 29.56 | 48.25 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3 | 13678-147E6 |
91.30 | 11.05 | 15.27 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1 | 13679-147E7 |
93.71 | 14.20 | 15.26 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2 | 13680-147E8 |
226.30 | 258.62 | 113.15 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3 | 13681-147E9 |
300.10 | 205.33 | 78.97 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1 | 13682-147F1 |
98.97 | 19.99 | 38.03 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2 | 13683-147F2 |
109.59 | 19.83 | 36.69 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3 | 13684-147F3 |
86.79 | 26.27 | 43.16 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1 | 13685-147F4 |
123.20 | 37.09 | 81.80 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2 | 13686-147F5 |
94.66 | 22.27 | 50.11 |
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3 | 13687-147F6 |
77.05 | 21.40 | 35.47 |
Adipocyte - breast, donor1 | 11376-118A8 |
519.02 | 48.47 | 42.13 |
Adipocyte - breast, donor2 | 11327-117E4 |
186.90 | 28.72 | 27.43 |
Adipocyte - omental, donor1 | 11473-119C6 |
654.46 | 54.20 | 37.79 |
Adipocyte - omental, donor2 | 11474-119C7 |
378.98 | 26.91 | 43.35 |
Adipocyte - omental, donor3 | 11475-119C8 |
265.59 | 20.76 | 33.49 |
Adipocyte - perirenal, donor1 | 11476-119C9 |
273.70 | 23.61 | 51.68 |
Adipocyte - subcutaneous, donor1 | 11259-116F8 |
94.56 | 23.09 | 23.09 |
Adipocyte - subcutaneous, donor2 | 11336-117F4 |
284.52 | 21.68 | 25.29 |
Adipocyte - subcutaneous, donor3 | 11408-118E4 |
78.37 | 11.64 | 10.77 |
Adipocyte differentiation, day04, donor1 | 13019-139D4 |
213.17 | 40.09 | 27.58 |
Adipocyte differentiation, day04, donor2 | 13022-139D7 |
116.34 | 22.65 | 27.80 |
Adipocyte differentiation, day04, donor3 | 13025-139E1 |
321.15 | 29.27 | 39.03 |
Adipocyte differentiation, day04, donor4 | 13028-139E4 |
153.42 | 24.69 | 18.81 |
Adipocyte differentiation, day08, donor1 | 13020-139D5 |
124.99 | 24.21 | 22.84 |
Adipocyte differentiation, day08, donor2 | 13023-139D8 |
160.73 | 23.24 | 34.53 |
Adipocyte differentiation, day08, donor3 | 13026-139E2 |
181.82 | 28.79 | 28.26 |
Adipocyte differentiation, day08, donor4 | 13029-139E5 |
142.45 | 16.69 | 21.14 |
Adipocyte differentiation, day12, donor1 | 13021-139D6 |
91.08 | 18.30 | 25.37 |
Adipocyte differentiation, day12, donor2 | 13024-139D9 |
193.40 | 20.60 | 34.66 |
Adipocyte differentiation, day12, donor3 | 13027-139E3 |
171.48 | 19.31 | 16.69 |
Adipocyte differentiation, day12, donor4 | 13030-139E6 |
89.82 | 9.44 | 11.57 |
Alveolar Epithelial Cells, donor1 | 11510-119G7 |
302.10 | 56.58 | 77.79 |
Alveolar Epithelial Cells, donor2 | 11590-120G6 |
127.30 | 12.19 | 22.95 |
Alveolar Epithelial Cells, donor3 | 11671-122G6 |
165.33 | 31.15 | 22.76 |
Amniotic Epithelial Cells, donor1 | 11533-120A3 |
171.63 | 36.34 | 39.76 |
Amniotic Epithelial Cells, donor2 | 11613-122A2 |
76.98 | 13.39 | 18.41 |
Amniotic Epithelial Cells, donor3 | 11694-123A2 |
223.12 | 36.98 | 40.47 |
Anulus Pulposus Cell, donor1 | 11248-116E6 |
418.11 | 57.67 | 41.08 |
Anulus Pulposus Cell, donor2 | 11463-119B5 |
263.03 | 25.47 | 23.51 |
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1) | 12642-134G5 |
368.87 | 31.00 | 51.67 |
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2) | 12740-135I4 |
301.29 | 22.58 | 45.15 |
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3) | 12838-137B3 |
462.29 | 49.23 | 70.63 |
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4) | 12643-134G6 |
417.89 | 40.35 | 49.92 |
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5) | 12741-135I5 |
328.81 | 25.29 | 63.23 |
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6) | 12839-137B4 |
466.01 | 35.64 | 35.64 |
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7) | 12644-134G7 |
346.98 | 31.19 | 44.18 |
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8) | 12742-135I6 |
300.00 | 30.58 | 47.57 |
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9) | 12840-137B5 |
515.49 | 53.45 | 38.60 |
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10) | 12645-134G8 |
409.40 | 41.43 | 54.24 |
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11) | 12743-135I7 |
309.86 | 31.20 | 43.54 |
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12) | 12841-137B6 |
458.88 | 40.12 | 41.37 |
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13) | 12646-134G9 |
617.43 | 52.88 | 47.28 |
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14) | 12744-135I8 |
256.58 | 27.30 | 62.78 |
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15) | 12842-137B7 |
718.22 | 60.92 | 55.19 |
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16) | 12647-134H1 |
354.69 | 28.93 | 38.04 |
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17) | 12745-135I9 |
421.52 | 37.60 | 41.75 |
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18) | 12843-137B8 |
447.70 | 38.22 | 43.83 |
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19) | 12648-134H2 |
266.30 | 38.04 | 44.87 |
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20) | 12746-136A1 |
411.83 | 45.61 | 42.96 |
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21) | 12844-137B9 |
512.71 | 44.43 | 43.23 |
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22) | 12649-134H3 |
226.57 | 46.02 | 42.48 |
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23) | 12747-136A2 |
324.02 | 34.48 | 37.39 |
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24) | 12845-137C1 |
574.71 | 41.95 | 54.53 |
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25) | 12650-134H4 |
316.50 | 36.41 | 46.60 |
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26) | 12748-136A3 |
432.95 | 59.95 | 47.05 |
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27) | 12846-137C2 |
451.84 | 42.40 | 39.98 |
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28) | 12651-134H5 |
343.16 | 34.20 | 57.00 |
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29) | 12749-136A4 |
344.61 | 33.35 | 33.14 |
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30) | 12847-137C3 |
388.43 | 30.71 | 35.62 |
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31) | 12652-134H6 |
285.28 | 28.15 | 47.86 |
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32) | 12750-136A5 |
331.84 | 28.94 | 36.98 |
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33) | 12848-137C4 |
490.85 | 41.38 | 41.38 |
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34) | 12653-134H7 |
284.29 | 26.91 | 40.95 |
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35) | 12751-136A6 |
355.87 | 40.95 | 41.25 |
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36) | 12849-137C5 |
456.19 | 48.71 | 48.71 |
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37) | 12654-134H8 |
382.44 | 39.16 | 51.87 |
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38) | 12752-136A7 |
471.68 | 52.72 | 45.84 |
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39) | 12850-137C6 |
468.27 | 46.38 | 48.29 |
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40) | 12655-134H9 |
264.53 | 30.21 | 45.74 |
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41) | 12753-136A8 |
424.43 | 47.42 | 40.64 |
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42) | 12851-137C7 |
416.12 | 35.38 | 32.48 |
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43) | 12656-134I1 |
231.46 | 27.40 | 45.35 |
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44) | 12754-136A9 |
366.00 | 41.87 | 44.42 |
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45) | 12852-137C8 |
421.58 | 41.69 | 34.75 |
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46) | 12657-134I2 |
211.26 | 31.69 | 42.25 |
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47) | 12755-136B1 |
324.62 | 38.17 | 42.02 |
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48) | 12853-137C9 |
558.34 | 36.70 | 32.49 |
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49) | 12658-134I3 |
314.19 | 26.97 | 52.49 |
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50) | 12756-136B2 |
439.30 | 47.82 | 45.06 |
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51) | 12854-137D1 |
372.34 | 35.70 | 38.25 |
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52) | 12659-134I4 |
1097.01 | 67.12 | 58.73 |
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53) | 12757-136B3 |
368.29 | 37.57 | 37.57 |
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54) | 12855-137D2 |
416.16 | 39.78 | 33.66 |
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55) | 12660-134I5 |
339.39 | 31.07 | 57.36 |
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56) | 12758-136B4 |
329.28 | 32.60 | 37.25 |
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57) | 12856-137D3 |
566.07 | 54.93 | 42.72 |
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58) | 12661-134I6 |
329.56 | 28.25 | 42.10 |
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59) | 12759-136B5 |
333.38 | 35.48 | 33.89 |
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60) | 12857-137D4 |
408.88 | 23.26 | 31.26 |
Astrocyte - cerebellum, donor1 | 11500-119F6 |
323.99 | 42.74 | 61.04 |
Astrocyte - cerebellum, donor2 | 11580-120F5 |
106.80 | 18.14 | 35.60 |
Astrocyte - cerebellum, donor3 | 11661-122F5 |
126.69 | 20.97 | 19.72 |
Astrocyte - cerebral cortex, donor1 | 11235-116D2 |
187.89 | 61.35 | 48.10 |
Astrocyte - cerebral cortex, donor2 | 11316-117D2 |
151.42 | 52.74 | 61.15 |
Astrocyte - cerebral cortex, donor3 | 11392-118C6 |
108.29 | 47.88 | 53.25 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1 | 10821-111C2 |
252.88 | 88.42 | 79.25 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2 | 10822-111C3 |
290.15 | 76.80 | 69.66 |
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3 | 10823-111C4 |
264.35 | 80.45 | 75.11 |
Basophils, donor1 | 12241-129G9 |
61.20 | 25.63 | 20.14 |
Basophils, donor2 | 12242-129H1 |
77.57 | 39.69 | 24.89 |
Basophils, donor3 | 12243-129H2 |
56.59 | 17.35 | 12.64 |
Bronchial Epithelial Cell, donor1 | 11511-119G8 |
326.85 | 35.14 | 32.77 |
Bronchial Epithelial Cell, donor2 | 11591-120G7 |
105.61 | 5.94 | 13.26 |
Bronchial Epithelial Cell, donor3 | 11672-122G7 |
1635.57 | 86.08 | 50.21 |
Bronchial Epithelial Cell, donor4 | 11453-119A4 |
658.41 | 49.58 | 70.30 |
Bronchial Epithelial Cell, donor5 | 11457-119A8 |
89.63 | 6.24 | 11.85 |
Bronchial Epithelial Cell, donor6 | 11461-119B3 |
167.42 | 13.13 | 28.79 |
Bronchial Epithelial Cell, donor7 | 11769-123I5 |
877.41 | 53.98 | 70.36 |
Burkitt's lymphoma cell line:DAUDI | 10422-106C8 |
176.74 | 56.17 | 95.33 |
Burkitt's lymphoma cell line:RAJI | 10476-106I8 |
398.96 | 111.33 | 131.36 |
CD133+ stem cells - adult bone marrow derived, pool1 | 12224-129F1 |
465.59 | 139.74 | 92.10 |
CD133+ stem cells - cord blood derived, pool1 | 12223-129E9 |
341.28 | 82.74 | 103.42 |
CD14+ Monocytes, donor1 | 11224-116B9 |
75.52 | 19.72 | 19.72 |
CD14+ Monocytes, donor2 | 11305-117B9 |
24.68 | 9.47 | 9.47 |
CD14+ Monocytes, donor3 | 11381-118B4 |
29.86 | 10.98 | 12.07 |
CD14+ monocyte derived endothelial progenitor cells, donor1 | 11229-116C5 |
794.79 | 43.87 | 45.85 |
CD14+ monocyte derived endothelial progenitor cells, donor2 | 11310-117C5 |
1293.02 | 48.14 | 39.80 |
CD14+ monocyte derived endothelial progenitor cells, donor3 | 11386-118B9 |
724.54 | 49.31 | 35.83 |
CD14+ monocytes - mock treated, donor1 | 11863-125A9 |
75.31 | 14.45 | 19.23 |
CD14+ monocytes - mock treated, donor2 | 11873-125C1 |
77.25 | 11.47 | 15.39 |
CD14+ monocytes - mock treated, donor3 | 11883-125D2 |
52.35 | 14.45 | 16.11 |
CD14+ monocytes - treated with B-glucan, donor1 | 11869-125B6 |
125.55 | 10.04 | 19.75 |
CD14+ monocytes - treated with B-glucan, donor2 | 11879-125C7 |
214.46 | 15.18 | 24.29 |
CD14+ monocytes - treated with B-glucan, donor3 | 11889-125D8 |
379.83 | 29.01 | 39.42 |
CD14+ monocytes - treated with BCG, donor1 | 11860-125A6 |
550.00 | 26.63 | 31.33 |
CD14+ monocytes - treated with BCG, donor2 | 11870-125B7 |
409.33 | 19.23 | 29.56 |
CD14+ monocytes - treated with BCG, donor3 | 11880-125C8 |
864.43 | 51.36 | 63.77 |
CD14+ monocytes - treated with Candida, donor1 | 11868-125B5 |
338.08 | 12.17 | 21.77 |
CD14+ monocytes - treated with Candida, donor2 | 11878-125C6 |
434.57 | 15.31 | 30.63 |
CD14+ monocytes - treated with Candida, donor3 | 11888-125D7 |
462.60 | 31.06 | 31.06 |
CD14+ monocytes - treated with Cryptococcus, donor1 | 11867-125B4 |
93.12 | 13.09 | 20.38 |
CD14+ monocytes - treated with Cryptococcus, donor2 | 11877-125C5 |
200.74 | 16.36 | 31.13 |
CD14+ monocytes - treated with Cryptococcus, donor3 | 11887-125D6 |
459.70 | 56.21 | 55.17 |
CD14+ monocytes - treated with Group A streptococci, donor1 | 11864-125B1 |
426.68 | 21.96 | 34.32 |
CD14+ monocytes - treated with Group A streptococci, donor2 | 11874-125C2 |
588.81 | 28.28 | 31.22 |
CD14+ monocytes - treated with Group A streptococci, donor3 | 11884-125D3 |
423.37 | 24.01 | 18.77 |
CD14+ monocytes - treated with IFN + N-hexane, donor1 | 11861-125A7 |
207.93 | 20.71 | 28.51 |
CD14+ monocytes - treated with IFN + N-hexane, donor2 | 11871-125B8 |
285.42 | 23.03 | 29.66 |
CD14+ monocytes - treated with IFN + N-hexane, donor3 | 11881-125C9 |
189.37 | 24.83 | 26.51 |
CD14+ monocytes - treated with Salmonella, donor1 | 11866-125B3 |
296.88 | 25.17 | 31.41 |
CD14+ monocytes - treated with Salmonella, donor2 | 11876-125C4 |
553.41 | 29.24 | 34.17 |
CD14+ monocytes - treated with Salmonella, donor3 | 11886-125D5 |
568.15 | 33.78 | 50.89 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1 | 11862-125A8 |
417.97 | 22.49 | 23.02 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2 | 11872-125B9 |
316.67 | 17.47 | 30.48 |
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3 | 11882-125D1 |
793.22 | 59.71 | 57.34 |
CD14+ monocytes - treated with lipopolysaccharide, donor1 | 11865-125B2 |
289.92 | 22.93 | 31.12 |
CD14+ monocytes - treated with lipopolysaccharide, donor2 | 11875-125C3 |
579.03 | 33.15 | 41.96 |
CD14+ monocytes - treated with lipopolysaccharide, donor3 | 11885-125D4 |
747.25 | 54.98 | 63.57 |
CD14+CD16+ Monocytes, donor1 | 11789-124B7 |
39.89 | 27.90 | 29.21 |
CD14+CD16+ Monocytes, donor2 | 11801-124D1 |
48.05 | 19.87 | 20.10 |
CD14+CD16+ Monocytes, donor3 | 11912-125G4 |
59.57 | 34.01 | 32.71 |
CD14+CD16- Monocytes, donor1 | 11788-124B6 |
75.84 | 29.59 | 35.97 |
CD14+CD16- Monocytes, donor2 | 11799-124C8 |
70.21 | 22.53 | 27.59 |
CD14+CD16- Monocytes, donor3 | 11910-125G2 |
53.29 | 32.33 | 32.55 |
CD14-CD16+ Monocytes, donor1 | 11790-124B8 |
40.32 | 22.46 | 25.26 |
CD14-CD16+ Monocytes, donor2 | 11800-124C9 |
31.18 | 16.25 | 14.27 |
CD14-CD16+ Monocytes, donor3 | 11911-125G3 |
26.74 | 19.58 | 21.69 |
CD19+ B Cells (pluriselect), donor090309, donation1 | 12189-129B2 |
56.90 | 32.52 | 30.48 |
CD19+ B Cells (pluriselect), donor090309, donation2 | 12194-129B7 |
58.31 | 29.15 | 34.58 |
CD19+ B Cells (pluriselect), donor090309, donation3 | 12199-129C3 |
61.10 | 29.00 | 30.03 |
CD19+ B Cells (pluriselect), donor090325, donation1 | 12151-128F9 |
79.42 | 26.65 | 26.65 |
CD19+ B Cells (pluriselect), donor090325, donation2 | 12174-128I5 |
50.93 | 24.66 | 28.95 |
CD19+ B Cells (pluriselect), donor090612, donation1 | 12204-129C8 |
63.17 | 29.48 | 30.89 |
CD19+ B Cells (pluriselect), donor090612, donation2 | 12209-129D4 |
76.08 | 21.96 | 28.24 |
CD19+ B Cells (pluriselect), donor090612, donation3 | 12214-129D9 |
81.73 | 17.14 | 44.82 |
CD19+ B Cells, donor1 | 11544-120B5 |
3.29 | 5.75 | 6.58 |
CD19+ B Cells, donor2 | 11624-122B4 |
10.88 | 8.71 | 7.98 |
CD19+ B Cells, donor3 | 11705-123B4 |
5.55 | 8.58 | 8.58 |
CD34 cells differentiated to erythrocyte lineage, biol_ rep1 | 11931-125I5 |
451.33 | 153.95 | 156.77 |
CD34 cells differentiated to erythrocyte lineage, biol_ rep2 | 11932-125I6 |
532.92 | 162.99 | 154.20 |
CD34+ Progenitors, donor1 | 11545-120B6 |
341.38 | 56.23 | 55.22 |
CD34+ Progenitors, donor2 | 11625-122B5 |
282.59 | 43.82 | 61.80 |
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1 | 12225-129F2 |
304.74 | 96.94 | 88.68 |
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2 | 12225-129F2 |
484.11 | 153.78 | 122.66 |
CD4+ T Cells, donor1 | 11225-116C1 |
22.14 | 10.35 | 8.21 |
CD4+ T Cells, donor2 | 11306-117C1 |
40.42 | 11.63 | 15.31 |
CD4+ T Cells, donor3 | 11382-118B5 |
31.41 | 13.11 | 16.47 |
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1 | 11793-124C2 |
171.52 | 65.09 | 67.89 |
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2 | 11915-125G7 |
192.93 | 70.97 | 59.97 |
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3 | 11919-125H2 |
147.75 | 47.72 | 58.64 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor1 | 11780-124A7 |
25.13 | 22.28 | 22.76 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor2 | 11796-124C5 |
40.73 | 31.60 | 37.22 |
CD4+CD25+CD45RA+ naive regulatory T cells, donor3 | 11907-125F8 |
9.89 | 16.48 | 13.18 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1 | 11794-124C3 |
161.13 | 48.70 | 46.39 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2 | 11916-125G8 |
144.89 | 53.72 | 55.75 |
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3 | 11920-125H3 |
148.63 | 54.97 | 59.65 |
CD4+CD25+CD45RA- memory regulatory T cells, donor1 | 11782-124A9 |
80.69 | 37.66 | 32.73 |
CD4+CD25+CD45RA- memory regulatory T cells, donor2 | 11797-124C6 |
106.91 | 41.93 | 57.65 |
CD4+CD25+CD45RA- memory regulatory T cells, donor3 | 11908-125F9 |
67.32 | 42.68 | 49.28 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1 | 11791-124B9 |
70.41 | 29.51 | 49.33 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2 | 11913-125G5 |
76.25 | 36.98 | 44.88 |
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3 | 11917-125G9 |
108.26 | 35.42 | 53.46 |
CD4+CD25-CD45RA+ naive conventional T cells, donor1 | 11784-124B2 |
16.59 | 11.69 | 15.50 |
CD4+CD25-CD45RA+ naive conventional T cells, donor2 | 11795-124C4 |
12.86 | 16.08 | 18.22 |
CD4+CD25-CD45RA+ naive conventional T cells, donor3 | 11906-125F7 |
14.35 | 14.35 | 10.76 |
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1 | 11792-124C1 |
157.06 | 55.81 | 60.08 |
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2 | 11914-125G6 |
149.90 | 62.39 | 61.30 |
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3 | 11918-125H1 |
151.94 | 59.68 | 62.20 |
CD4+CD25-CD45RA- memory conventional T cells, donor1 | 11786-124B4 |
73.31 | 43.48 | 34.89 |
CD4+CD25-CD45RA- memory conventional T cells, donor2 | 11798-124C7 |
93.58 | 46.36 | 45.06 |
CD4+CD25-CD45RA- memory conventional T cells, donor3 | 11909-125G1 |
72.35 | 44.02 | 42.27 |
CD8+ T Cells (pluriselect), donor090309, donation1 | 12186-129A8 |
94.52 | 44.04 | 45.03 |
CD8+ T Cells (pluriselect), donor090309, donation2 | 12191-129B4 |
82.16 | 38.77 | 54.47 |
CD8+ T Cells (pluriselect), donor090309, donation3 | 12196-129B9 |
80.96 | 72.58 | 61.42 |
CD8+ T Cells (pluriselect), donor090325, donation1 | 12148-128F6 |
70.62 | 32.40 | 40.15 |
CD8+ T Cells (pluriselect), donor090325, donation2 | 12171-128I2 |
65.27 | 31.16 | 45.40 |
CD8+ T Cells (pluriselect), donor090612, donation1 | 12201-129C5 |
81.62 | 52.36 | 47.74 |
CD8+ T Cells (pluriselect), donor090612, donation2 | 12206-129D1 |
110.66 | 48.70 | 55.15 |
CD8+ T Cells (pluriselect), donor090612, donation3 | 12211-129D6 |
109.41 | 65.09 | 59.55 |
CD8+ T Cells, donor1 | 11226-116C2 |
29.79 | 11.13 | 15.39 |
CD8+ T Cells, donor2 | 11307-117C2 |
29.28 | 13.89 | 13.52 |
CD8+ T Cells, donor3 | 11383-118B6 |
21.21 | 10.10 | 8.08 |
COBL-a rinderpest infection, 00hr, biol_rep1 | 13553-145I7 |
1652.77 | 15.60 | 27.07 |
COBL-a rinderpest infection, 00hr, biol_rep2 | 13554-145I8 |
1532.51 | 12.46 | 19.65 |
COBL-a rinderpest infection, 00hr, biol_rep3 | 13555-145I9 |
1956.73 | 21.07 | 28.18 |
COBL-a rinderpest infection, 06hr, biol_rep1 | 13556-146A1 |
2573.41 | 24.62 | 43.23 |
COBL-a rinderpest infection, 06hr, biol_rep2 | 13557-146A2 |
1465.09 | 10.32 | 24.24 |
COBL-a rinderpest infection, 06hr, biol_rep3 | 13558-146A3 |
1603.07 | 15.92 | 27.74 |
COBL-a rinderpest infection, 12hr, biol_rep1 | 13559-146A4 |
2111.35 | 20.86 | 26.29 |
COBL-a rinderpest infection, 12hr, biol_rep2 | 13560-146A5 |
2199.60 | 15.00 | 30.53 |
COBL-a rinderpest infection, 12hr, biol_rep3 | 13561-146A6 |
2046.15 | 14.77 | 29.08 |
COBL-a rinderpest infection, 24hr, biol_rep1 | 13562-146A7 |
2171.71 | 19.32 | 26.26 |
COBL-a rinderpest infection, 24hr, biol_rep2 | 13563-146A8 |
1942.02 | 15.69 | 25.56 |
COBL-a rinderpest infection, 24hr, biol_rep3 | 13564-146A9 |
1562.90 | 26.64 | 33.84 |
COBL-a rinderpest infection, 48hr, biol_rep1 | 13565-146B1 |
1340.83 | 12.69 | 15.32 |
COBL-a rinderpest infection, 48hr, biol_rep2 | 13566-146B2 |
1479.69 | 18.67 | 20.95 |
COBL-a rinderpest infection, 48hr, biol_rep3 | 13567-146B3 |
1315.72 | 9.70 | 20.88 |
COBL-a rinderpest(-C) infection, 06hr, biol_rep1 | 13568-146B4 |
1636.19 | 20.53 | 25.21 |
COBL-a rinderpest(-C) infection, 06hr, biol_rep2 | 13569-146B5 |
1640.59 | 13.52 | 23.88 |
COBL-a rinderpest(-C) infection, 06hr, biol_rep3 | 13570-146B6 |
1648.93 | 21.92 | 24.51 |
COBL-a rinderpest(-C) infection, 12hr, biol_rep1 | 13571-146B7 |
1928.04 | 26.94 | 38.98 |
COBL-a rinderpest(-C) infection, 12hr, biol_rep2 | 13572-146B8 |
1817.70 | 23.07 | 27.37 |
COBL-a rinderpest(-C) infection, 12hr, biol_rep3 | 13573-146B9 |
1599.07 | 17.95 | 32.06 |
COBL-a rinderpest(-C) infection, 24hr, biol_rep1 | 13574-146C1 |
1901.24 | 16.45 | 33.27 |
COBL-a rinderpest(-C) infection, 24hr, biol_rep2 | 13575-146C2 |
1649.33 | 17.73 | 27.19 |
COBL-a rinderpest(-C) infection, 24hr, biol_rep3 | 13576-146C3 |
1748.07 | 10.59 | 19.67 |
COBL-a rinderpest(-C) infection, 48hr, biol_rep1 | 13577-146C4 |
918.58 | 8.03 | 23.29 |
COBL-a rinderpest(-C) infection, 48hr, biol_rep2 | 13578-146C5 |
935.84 | 16.09 | 25.18 |
COBL-a rinderpest(-C) infection, 48hr, biol_rep3 | 13579-146C6 |
694.21 | 13.02 | 35.06 |
Cardiac Myocyte, donor1 | 11525-119I4 |
244.92 | 25.59 | 25.59 |
Cardiac Myocyte, donor2 | 11605-120I3 |
223.33 | 39.03 | 53.36 |
Cardiac Myocyte, donor3 | 11686-122I3 |
402.20 | 68.82 | 57.88 |
Chondrocyte - de diff, donor1 | 11261-116G1 |
826.80 | 37.44 | 28.77 |
Chondrocyte - de diff, donor2 | 11338-117F6 |
324.10 | 22.03 | 22.74 |
Chondrocyte - de diff, donor3 | 11410-118E6 |
430.99 | 29.24 | 16.38 |
Chondrocyte - re diff, donor2 | 11339-117F7 |
249.78 | 28.65 | 41.18 |
Chondrocyte - re diff, donor3 | 11411-118E7 |
136.28 | 28.31 | 23.86 |
Ciliary Epithelial Cells, donor1 | 11242-116D9 |
312.49 | 84.12 | 66.45 |
Ciliary Epithelial Cells, donor2 | 11323-117D9 |
242.20 | 67.34 | 55.58 |
Ciliary Epithelial Cells, donor3 | 11399-118D4 |
147.26 | 37.97 | 34.34 |
Clontech Human Universal Reference Total RNA, pool1 | 10000-101A1 |
128.75 | 18.16 | 12.20 |
Corneal Epithelial Cells, donor1 | 11526-119I5 |
196.74 | 24.59 | 34.25 |
Corneal Epithelial Cells, donor2 | 11606-120I4 |
200.22 | 22.75 | 23.89 |
Corneal Epithelial Cells, donor3 | 11687-122I4 |
334.36 | 35.53 | 39.11 |
Dendritic Cells - monocyte immature derived, donor1, rep2 | 11227-116C3 |
4544.42 | 15.52 | 10.24 |
Dendritic Cells - monocyte immature derived, donor1, tech_rep1 | 11227-116C3 |
4850.68 | 15.77 | 11.35 |
Dendritic Cells - monocyte immature derived, donor2 | 11308-117C3 |
8443.86 | 34.51 | 20.70 |
Dendritic Cells - monocyte immature derived, donor3 | 11384-118B7 |
1445.33 | 13.07 | 10.80 |
Dendritic Cells - plasmacytoid, donor1 | 11228-116C4 |
473.17 | 59.45 | 59.10 |
Dendritic Cells - plasmacytoid, donor2 | 11309-117C4 |
1540.77 | 201.08 | 131.23 |
Dendritic Cells - plasmacytoid, donor3 | 11385-118B8 |
783.99 | 68.72 | 110.34 |
Endothelial Cells - Aortic, donor0 | 11207-116A1 |
229.64 | 27.18 | 33.35 |
Endothelial Cells - Aortic, donor1 | 11263-116G3 |
112.07 | 26.40 | 34.62 |
Endothelial Cells - Aortic, donor2 | 11340-117F8 |
131.22 | 23.75 | 35.35 |
Endothelial Cells - Aortic, donor3 | 11412-118E8 |
98.69 | 14.94 | 15.33 |
Endothelial Cells - Artery, donor1 | 11264-116G4 |
79.12 | 19.49 | 23.85 |
Endothelial Cells - Artery, donor2 | 11341-117F9 |
88.23 | 26.82 | 33.88 |
Endothelial Cells - Artery, donor3 | 11413-118E9 |
116.23 | 23.32 | 30.33 |
Endothelial Cells - Lymphatic, donor1 | 11236-116D3 |
306.77 | 36.13 | 38.35 |
Endothelial Cells - Lymphatic, donor2 | 11317-117D3 |
275.06 | 37.12 | 30.12 |
Endothelial Cells - Lymphatic, donor3 | 11393-118C7 |
119.25 | 30.16 | 26.50 |
Endothelial Cells - Microvascular, donor1 | 11265-116G5 |
237.11 | 26.44 | 45.16 |
Endothelial Cells - Microvascular, donor2 | 11342-117G1 |
205.14 | 40.61 | 52.59 |
Endothelial Cells - Microvascular, donor3 | 11414-118F1 |
56.29 | 12.19 | 14.04 |
Endothelial Cells - Thoracic, donor1 | 11266-116G6 |
338.90 | 51.22 | 78.82 |
Endothelial Cells - Thoracic, donor2 | 11343-117G2 |
65.52 | 12.58 | 18.34 |
Endothelial Cells - Umbilical vein, donor1 | 11243-116E1 |
244.52 | 68.96 | 73.68 |
Endothelial Cells - Umbilical vein, donor2 | 11324-117E1 |
97.12 | 28.46 | 32.59 |
Endothelial Cells - Umbilical vein, donor3 | 11400-118D5 |
99.41 | 31.26 | 39.94 |
Endothelial Cells - Vein, donor1 | 11267-116G7 |
69.39 | 10.24 | 18.20 |
Endothelial Cells - Vein, donor2 | 11344-117G3 |
58.67 | 7.68 | 11.87 |
Endothelial Cells - Vein, donor3 | 11416-118F3 |
111.95 | 28.26 | 38.31 |
Eosinophils, donor1 | 12244-129H3 |
91.48 | 45.74 | 0.00 |
Eosinophils, donor2 | 12245-129H4 |
150.17 | 66.01 | 61.06 |
Eosinophils, donor3 | 12246-129H5 |
281.78 | 85.60 | 78.47 |
Esophageal Epithelial Cells, donor1 | 11507-119G4 |
300.03 | 32.50 | 32.74 |
Esophageal Epithelial Cells, donor2 | 11587-120G3 |
110.25 | 4.16 | 12.48 |
Esophageal Epithelial Cells, donor3 | 11668-122G3 |
959.86 | 48.81 | 32.54 |
Ewing's sarcoma cell line:Hs 863.T | 10705-109H3 |
231.94 | 29.56 | 23.81 |
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction) | 14331-155F2 |
730.84 | 25.73 | 25.95 |
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction) | 14310-155C8 |
627.28 | 43.44 | 40.41 |
Fibroblast - Aortic Adventitial, donor1 | 11245-116E3 |
596.21 | 68.89 | 46.09 |
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction) | 14332-155F3 |
646.74 | 26.20 | 17.20 |
Fibroblast - Aortic Adventitial, donor2 | 11326-117E3 |
314.82 | 25.84 | 19.62 |
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction) | 14311-155C9 |
236.35 | 16.07 | 15.81 |
Fibroblast - Aortic Adventitial, donor3 | 11401-118D6 |
400.97 | 40.86 | 43.19 |
Fibroblast - Cardiac, donor1 | 11268-116G8 |
350.65 | 44.00 | 30.39 |
Fibroblast - Cardiac, donor2 | 11345-117G4 |
112.18 | 19.71 | 20.46 |
Fibroblast - Cardiac, donor3 | 11417-118F4 |
136.27 | 21.92 | 21.13 |
Fibroblast - Cardiac, donor4 | 11452-119A3 |
381.92 | 47.28 | 25.76 |
Fibroblast - Cardiac, donor5 | 11456-119A7 |
169.80 | 29.31 | 44.42 |
Fibroblast - Cardiac, donor6 | 11460-119B2 |
352.30 | 42.75 | 58.36 |
Fibroblast - Choroid Plexus, donor1 | 11492-119E7 |
222.16 | 21.57 | 25.86 |
Fibroblast - Choroid Plexus, donor2 | 11572-120E6 |
151.86 | 31.49 | 26.75 |
Fibroblast - Choroid Plexus, donor3 | 11653-122E6 |
117.18 | 60.06 | 80.56 |
Fibroblast - Conjunctival, donor1 | 11531-120A1 |
102.63 | 23.53 | 28.60 |
Fibroblast - Conjunctival, donor3 | 11692-122I9 |
338.53 | 34.26 | 24.93 |
Fibroblast - Dermal, donor1 | 11269-116G9 |
335.74 | 49.77 | 47.66 |
Fibroblast - Dermal, donor2 | 11346-117G5 |
222.16 | 41.04 | 48.58 |
Fibroblast - Dermal, donor3 | 11418-118F5 |
332.44 | 49.81 | 45.69 |
Fibroblast - Dermal, donor4 | 11450-119A1 |
154.31 | 41.15 | 65.00 |
Fibroblast - Dermal, donor5 | 11454-119A5 |
177.07 | 47.10 | 88.10 |
Fibroblast - Dermal, donor6 | 11458-119A9 |
213.91 | 61.88 | 108.82 |
Fibroblast - Gingival, donor1 | 11237-116D4 |
556.39 | 64.55 | 51.85 |
Fibroblast - Gingival, donor10 (periodontitis) | 11928-125I2 |
385.14 | 56.07 | 36.16 |
Fibroblast - Gingival, donor2 | 11318-117D4 |
308.37 | 78.41 | 90.14 |
Fibroblast - Gingival, donor3 | 11394-118C8 |
226.83 | 22.72 | 28.23 |
Fibroblast - Gingival, donor4 (GFH2) | 11222-116B7 |
632.69 | 40.52 | 41.56 |
Fibroblast - Gingival, donor5 (GFH3) | 11303-117B7 |
292.32 | 19.73 | 19.03 |
Fibroblast - Gingival, donor6 (aggressive periodontitis) | 11921-125H4 |
605.19 | 75.61 | 53.32 |
Fibroblast - Gingival, donor6 (control) | 11922-125H5 |
683.98 | 60.18 | 61.53 |
Fibroblast - Gingival, donor7 (aggressive periodontitis) | 11923-125H6 |
39.52 | 4.23 | 7.06 |
Fibroblast - Gingival, donor7 (control) | 11924-125H7 |
459.06 | 54.26 | 51.48 |
Fibroblast - Gingival, donor8 (chronic periodontitis) | 11925-125H8 |
532.46 | 62.18 | 57.54 |
Fibroblast - Gingival, donor8 (control) | 11926-125H9 |
483.31 | 60.22 | 55.07 |
Fibroblast - Gingival, donor9 (control) | 11927-125I1 |
379.91 | 30.96 | 27.00 |
Fibroblast - Lung, donor1 | 11270-116H1 |
78.84 | 19.03 | 21.75 |
Fibroblast - Lung, donor2 | 11347-117G6 |
196.96 | 62.67 | 52.23 |
Fibroblast - Lung, donor3 | 11419-118F6 |
112.06 | 36.93 | 46.64 |
Fibroblast - Lymphatic, donor1 | 11506-119G3 |
326.54 | 28.32 | 34.99 |
Fibroblast - Lymphatic, donor2 | 11586-120G2 |
121.68 | 6.99 | 20.98 |
Fibroblast - Lymphatic, donor3 | 11667-122G2 |
113.35 | 9.24 | 14.55 |
Fibroblast - Mammary, donor1 | 11540-120B1 |
199.74 | 50.34 | 49.12 |
Fibroblast - Mammary, donor2 | 11620-122A9 |
87.87 | 15.98 | 31.95 |
Fibroblast - Mammary, donor3 | 11701-123A9 |
148.91 | 5.96 | 29.78 |
Fibroblast - Periodontal Ligament, donor1 | 11238-116D5 |
424.61 | 85.54 | 88.65 |
Fibroblast - Periodontal Ligament, donor2 | 11319-117D5 |
169.58 | 50.21 | 55.82 |
Fibroblast - Periodontal Ligament, donor3 | 11395-118C9 |
395.95 | 52.02 | 41.92 |
Fibroblast - Periodontal Ligament, donor4 (PL29) | 11223-116B8 |
242.71 | 36.25 | 37.40 |
Fibroblast - Periodontal Ligament, donor5 (PL30) | 11304-117B8 |
294.56 | 45.36 | 35.37 |
Fibroblast - Periodontal Ligament, donor6 (PLH3) | 11380-118B3 |
234.85 | 18.79 | 16.47 |
Fibroblast - Pulmonary Artery, donor1 | 11250-116E8 |
635.89 | 89.64 | 64.55 |
Fibroblast - Villous Mesenchymal, donor1 | 11535-120A5 |
424.67 | 34.14 | 36.57 |
Fibroblast - Villous Mesenchymal, donor2 | 11615-122A4 |
128.96 | 28.73 | 48.78 |
Fibroblast - Villous Mesenchymal, donor3 | 11696-123A4 |
252.24 | 63.26 | 58.12 |
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction) | 14329-155E9 |
162.93 | 22.23 | 29.17 |
Fibroblast - skin dystrophia myotonica, donor1 | 11556-120C8 |
194.14 | 29.31 | 30.20 |
Fibroblast - skin dystrophia myotonica, donor2 | 11557-120C9 |
335.64 | 40.01 | 40.99 |
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction) | 14308-155C6 |
209.70 | 24.97 | 28.28 |
Fibroblast - skin dystrophia myotonica, donor3 | 11560-120D3 |
402.66 | 36.92 | 42.21 |
Fibroblast - skin normal, donor1 (nuclear fraction) | 14323-155E3 |
211.32 | 23.03 | 31.63 |
Fibroblast - skin normal, donor1 | 11553-120C5 |
349.49 | 44.96 | 36.59 |
Fibroblast - skin normal, donor2 (nuclear fraction) | 14302-155B9 |
201.11 | 33.69 | 27.07 |
Fibroblast - skin normal, donor2 | 11561-120D4 |
404.26 | 54.85 | 58.87 |
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction) | 14326-155E6 |
249.04 | 25.99 | 40.20 |
Fibroblast - skin spinal muscular atrophy, donor1 | 11555-120C7 |
349.53 | 48.30 | 33.47 |
Fibroblast - skin spinal muscular atrophy, donor2 | 11558-120D1 |
651.66 | 31.63 | 39.66 |
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction) | 14305-155C3 |
131.37 | 12.15 | 22.00 |
Fibroblast - skin spinal muscular atrophy, donor3 | 11559-120D2 |
388.48 | 50.49 | 56.14 |
Fibroblast - skin walker warburg, donor1 | 11554-120C6 |
327.41 | 63.09 | 70.34 |
Fibroblast - skin, normal donor1 (cytoplasmic fraction) | 14322-155E2 |
769.67 | 106.32 | 99.11 |
Fibroblast - skin, normal donor2 (cytoplasmic fraction) | 14301-155B8 |
2149.50 | 775.59 | 531.84 |
Fingernail (including nail plate, eponychium and hyponychium), donor2 | 10301-104H4 |
291.09 | 36.60 | 30.50 |
Gingival epithelial cells, donor1 (GEA11) | 11221-116B6 |
1063.90 | 73.50 | 68.13 |
Gingival epithelial cells, donor2 (GEA14) | 11302-117B6 |
636.81 | 78.33 | 54.91 |
Gingival epithelial cells, donor3 (GEA15) | 11379-118B2 |
744.56 | 60.05 | 47.78 |
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1 | 13523-145F4 |
199.81 | 31.39 | 73.49 |
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2 | 13524-145F5 |
276.29 | 50.41 | 96.35 |
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3 | 13525-145F6 |
385.68 | 180.00 | 229.07 |
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1 | 13526-145F7 |
53.22 | 66.73 | 72.80 |
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2 | 13527-145F8 |
104.80 | 48.41 | 48.86 |
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3 | 13528-145F9 |
204.87 | 89.36 | 121.85 |
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1 | 13529-145G1 |
50.75 | 69.52 | 83.79 |
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2 | 13530-145G2 |
102.41 | 41.09 | 42.07 |
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3 | 13531-145G3 |
336.97 | 111.88 | 207.85 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0) | 12627-134E8 |
68.12 | 52.57 | 105.85 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0) | 12725-135G7 |
72.78 | 37.44 | 66.00 |
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0) | 12823-136I6 |
127.60 | 61.52 | 67.16 |
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1) | 12628-134E9 |
77.93 | 53.65 | 101.59 |
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1) | 12726-135G8 |
80.56 | 54.12 | 107.00 |
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1) | 12824-136I7 |
151.66 | 74.41 | 104.29 |
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3) | 12629-134F1 |
89.67 | 53.39 | 69.37 |
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3) | 12727-135G9 |
68.01 | 46.09 | 80.72 |
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3) | 12825-136I8 |
88.52 | 37.60 | 61.20 |
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6) | 12630-134F2 |
80.96 | 59.39 | 72.69 |
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6) | 12728-135H1 |
64.22 | 40.06 | 78.05 |
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6) | 12826-136I9 |
86.24 | 45.35 | 62.33 |
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9) | 12631-134F3 |
63.51 | 46.78 | 50.21 |
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9) | 12729-135H2 |
92.12 | 54.96 | 83.46 |
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9) | 12827-137A1 |
188.43 | 67.48 | 73.07 |
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12) | 12632-134F4 |
79.71 | 52.03 | 55.67 |
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12) | 12632-134F4 |
72.24 | 50.21 | 70.70 |
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12) | 12730-135H3 |
58.43 | 39.50 | 57.32 |
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12) | 12828-137A2 |
175.04 | 65.73 | 70.88 |
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12) | 12828-137A2 |
151.30 | 57.17 | 77.38 |
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15) | 12633-134F5 |
86.03 | 63.95 | 75.71 |
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15) | 12731-135H4 |
52.23 | 39.32 | 60.30 |
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15) | 12829-137A3 |
109.90 | 48.53 | 56.53 |
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18) | 12634-134F6 |
53.34 | 33.95 | 45.41 |
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18) | 12732-135H5 |
55.96 | 48.09 | 74.78 |
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18) | 12830-137A4 |
105.36 | 45.39 | 57.71 |
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21) | 12635-134F7 |
48.75 | 39.45 | 49.39 |
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21) | 12733-135H6 |
48.04 | 31.84 | 43.40 |
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21) | 12831-137A5 |
84.62 | 42.87 | 50.46 |
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24) | 12636-134F8 |
100.35 | 50.17 | 54.13 |
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24) | 12734-135H7 |
80.18 | 38.05 | 53.63 |
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24) | 12832-137A6 |
83.65 | 42.59 | 50.72 |
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27) | 12637-134F9 |
90.90 | 40.68 | 51.62 |
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27) | 12735-135H8 |
94.16 | 33.42 | 42.78 |
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27) | 12833-137A7 |
183.71 | 62.04 | 64.18 |
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30) | 12638-134G1 |
209.46 | 51.87 | 43.30 |
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30) | 12736-135H9 |
123.71 | 40.42 | 55.70 |
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30) | 12834-137A8 |
123.61 | 40.93 | 41.47 |
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34) | 12639-134G2 |
128.49 | 39.64 | 42.03 |
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34) | 12737-135I1 |
125.67 | 50.66 | 44.08 |
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34) | 12835-137A9 |
38.68 | 16.86 | 16.86 |
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41) | 12640-134G3 |
165.15 | 44.19 | 44.32 |
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41) | 12738-135I2 |
175.33 | 48.02 | 47.61 |
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41) | 12836-137B1 |
71.67 | 17.54 | 12.71 |
H9 Embryonic Stem cells, biol_rep1 (H9ES-1) | 12626-134E7 |
123.42 | 59.32 | 125.21 |
H9 Embryonic Stem cells, biol_rep2 (H9ES-2) | 12724-135G6 |
49.15 | 50.23 | 111.09 |
H9 Embryonic Stem cells, biol_rep3 (H9ES-3) | 12822-136I5 |
53.40 | 58.72 | 119.89 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1) | 13364-143F7 |
406.50 | 133.62 | 145.83 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2) | 13365-143F8 |
403.49 | 127.43 | 140.71 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3) | 13366-143F9 |
127.75 | 56.27 | 103.31 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1 | 13328-143B7 |
277.18 | 94.04 | 108.89 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2 | 13340-143D1 |
238.66 | 74.65 | 92.06 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3 | 13352-143E4 |
341.75 | 97.87 | 88.25 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1 | 13329-143B8 |
163.45 | 50.43 | 92.16 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2 | 13341-143D2 |
230.11 | 67.05 | 83.65 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3 | 13353-143E5 |
221.55 | 71.65 | 99.24 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1 | 13330-143B9 |
149.95 | 53.32 | 99.97 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2 | 13342-143D3 |
210.02 | 63.48 | 87.81 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3 | 13354-143E6 |
176.82 | 60.79 | 77.14 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1 | 13331-143C1 |
103.18 | 54.52 | 62.91 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2 | 13343-143D4 |
163.81 | 58.84 | 84.29 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3 | 13355-143E7 |
186.81 | 70.65 | 97.14 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1 | 13332-143C2 |
265.19 | 127.38 | 156.61 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2 | 13344-143D5 |
115.11 | 78.46 | 119.69 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3 | 13356-143E8 |
86.13 | 51.50 | 74.00 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1 | 13333-143C3 |
194.83 | 86.40 | 93.18 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2 | 13345-143D6 |
213.32 | 57.57 | 77.04 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3 | 13357-143E9 |
146.59 | 53.62 | 56.84 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1 | 13334-143C4 |
216.01 | 79.03 | 100.10 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2 | 13346-143D7 |
143.77 | 52.66 | 66.50 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3 | 13358-143F1 |
145.38 | 46.94 | 64.54 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1 | 13335-143C5 |
197.98 | 66.88 | 109.02 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2 | 13347-143D8 |
89.77 | 62.80 | 90.15 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3 | 13359-143F2 |
110.92 | 49.98 | 71.21 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1 | 13336-143C6 |
72.06 | 54.67 | 121.75 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2 | 13348-143D9 |
80.69 | 74.08 | 117.96 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3 | 13360-143F3 |
63.37 | 54.92 | 105.01 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1 | 13337-143C7 |
132.26 | 82.91 | 123.10 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2 | 13349-143E1 |
111.67 | 63.02 | 103.30 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3 | 13361-143F4 |
101.14 | 82.88 | 138.63 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1 | 13338-143C8 |
103.88 | 108.60 | 188.87 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2 | 13350-143E2 |
100.35 | 84.02 | 139.44 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3 | 13362-143F5 |
58.81 | 46.08 | 104.45 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1 | 13339-143C9 |
50.86 | 68.66 | 102.57 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2 | 13351-143E3 |
117.00 | 51.93 | 70.44 |
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3 | 13363-143F6 |
139.27 | 45.61 | 65.02 |
Hair Follicle Dermal Papilla Cells, donor1 | 11271-116H2 |
178.04 | 36.52 | 30.82 |
Hair Follicle Dermal Papilla Cells, donor2 | 11348-117G7 |
127.24 | 17.88 | 18.30 |
Hair Follicle Dermal Papilla Cells, donor3 | 11420-118F7 |
384.56 | 40.48 | 34.86 |
Hair Follicle Outer Root Sheath Cells, donor1 | 11504-119G1 |
228.99 | 19.03 | 20.93 |
Hair Follicle Outer Root Sheath Cells, donor2 | 11584-120F9 |
362.60 | 30.08 | 25.06 |
Hep-2 cells mock treated, biol_rep1 | 11898-125E8 |
734.31 | 72.76 | 86.57 |
Hep-2 cells mock treated, biol_rep2 | 11899-125E9 |
580.68 | 66.68 | 78.16 |
Hep-2 cells mock treated, biol_rep3 | 11900-125F1 |
568.76 | 57.10 | 91.46 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep1 | 11890-125D9 |
780.47 | 79.14 | 91.05 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep2 | 11891-125E1 |
574.03 | 62.11 | 89.62 |
Hep-2 cells treated with Streptococci strain 5448, biol_rep3 | 11892-125E2 |
555.21 | 60.92 | 86.97 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1 | 11894-125E4 |
737.01 | 69.12 | 88.17 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2 | 11895-125E5 |
625.47 | 68.79 | 88.69 |
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3 | 11896-125E6 |
586.60 | 71.44 | 93.87 |
Hepatic Sinusoidal Endothelial Cells, donor1 | 11521-119H9 |
80.03 | 17.35 | 27.98 |
Hepatic Sinusoidal Endothelial Cells, donor2 | 11601-120H8 |
90.02 | 18.18 | 32.03 |
Hepatic Sinusoidal Endothelial Cells, donor3 | 11682-122H8 |
288.17 | 60.81 | 31.73 |
Hepatic Stellate Cells (lipocyte), donor1 | 11524-119I3 |
244.44 | 30.33 | 40.21 |
Hepatic Stellate Cells (lipocyte), donor2 | 11604-120I2 |
128.59 | 19.62 | 21.80 |
Hepatic Stellate Cells (lipocyte), donor3 | 11685-122I2 |
393.91 | 60.14 | 57.17 |
Hepatocyte, donor1 | 11523-119I2 |
225.17 | 35.11 | 26.63 |
Hepatocyte, donor2 | 11603-120I1 |
151.90 | 24.78 | 47.40 |
Hepatocyte, donor3 | 11684-122I1 |
141.11 | 19.02 | 20.25 |
Hodgkin's lymphoma cell line:HD-Mar2 | 10435-106E3 |
590.03 | 76.36 | 80.93 |
Intestinal epithelial cells (polarized), donor1 | 11246-116E4 |
429.96 | 45.97 | 42.82 |
Iris Pigment Epithelial Cells, donor1 | 11530-119I9 |
367.58 | 71.48 | 68.05 |
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1 | 13079-140B1 |
19.10 | 19.10 | 28.66 |
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2 | 13145-140I4 |
26.70 | 26.70 | 46.73 |
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3 | 13211-141G7 |
27.08 | 27.08 | 81.25 |
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1 | 13080-140B2 |
23.53 | 11.08 | 30.46 |
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2 | 13146-140I5 |
22.52 | 20.02 | 10.01 |
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3 | 13212-141G8 |
130.55 | 35.60 | 23.74 |
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1 | 13081-140B3 |
15.38 | 10.25 | 23.07 |
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2 | 13147-140I6 |
9.14 | 9.14 | 27.42 |
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3 | 13213-141G9 |
37.36 | 16.24 | 40.61 |
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1 | 13082-140B4 |
21.67 | 21.67 | 16.67 |
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2 | 13148-140I7 |
21.78 | 10.89 | 36.31 |
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3 | 13214-141H1 |
38.38 | 9.26 | 33.09 |
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1 | 13083-140B5 |
32.15 | 17.74 | 24.39 |
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2 | 13149-140I8 |
73.34 | 5.24 | 20.95 |
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3 | 13215-141H2 |
35.90 | 33.38 | 54.17 |
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1 | 13084-140B6 |
29.39 | 12.37 | 18.56 |
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2 | 13150-140I9 |
0.00 | 29.27 | 43.90 |
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3 | 13216-141H3 |
32.30 | 23.26 | 43.28 |
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1 | 13085-140B7 |
25.76 | 14.49 | 28.98 |
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2 | 13151-141A1 |
47.79 | 35.84 | 11.95 |
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3 | 13217-141H4 |
40.74 | 21.19 | 47.26 |
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1 | 13086-140B8 |
33.17 | 20.15 | 14.69 |
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2 | 13152-141A2 |
14.37 | 28.74 | 28.74 |
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3 | 13218-141H5 |
38.58 | 20.90 | 31.34 |
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1 | 13087-140B9 |
29.55 | 24.01 | 23.08 |
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2 | 13153-141A3 |
15.08 | 0.00 | 45.24 |
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3 | 13219-141H6 |
35.40 | 20.30 | 34.46 |
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1 | 13088-140C1 |
30.84 | 15.42 | 25.40 |
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2 | 13154-141A4 |
29.48 | 14.74 | 29.48 |
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3 | 13220-141H7 |
35.51 | 19.37 | 24.75 |
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1 | 13089-140C2 |
24.14 | 17.79 | 30.49 |
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2 | 13155-141A5 |
0.00 | 16.43 | 16.43 |
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3 | 13221-141H8 |
26.14 | 14.03 | 33.16 |
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1 | 13090-140C3 |
18.23 | 16.40 | 30.99 |
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2 | 13156-141A6 |
0.00 | 15.80 | 15.80 |
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3 | 13222-141H9 |
22.14 | 14.28 | 23.56 |
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1 | 13091-140C4 |
13.27 | 26.55 | 36.50 |
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2 | 13157-141A7 |
0.00 | 0.00 | 20.85 |
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3 | 13223-141I1 |
48.77 | 30.87 | 50.62 |
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1 | 13092-140C5 |
17.56 | 12.29 | 15.80 |
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2 | 13158-141A8 |
31.43 | 9.43 | 22.00 |
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3 | 13224-141I2 |
24.34 | 13.21 | 26.42 |
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1 | 13093-140C6 |
26.56 | 13.28 | 30.98 |
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2 | 13159-141A9 |
32.42 | 22.69 | 25.94 |
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3 | 13225-141I3 |
14.82 | 9.59 | 22.67 |
K562 erythroblastic leukemia response to hemin, day02, biol_rep1 | 13094-140C7 |
20.25 | 9.00 | 20.25 |
K562 erythroblastic leukemia response to hemin, day02, biol_rep2 | 13160-141B1 |
17.42 | 20.91 | 27.88 |
K562 erythroblastic leukemia response to hemin, day02, biol_rep3 | 13226-141I4 |
24.54 | 19.20 | 39.47 |
K562 erythroblastic leukemia response to hemin, day03, biol_rep1 | 13095-140C8 |
22.17 | 15.24 | 19.40 |
K562 erythroblastic leukemia response to hemin, day03, biol_rep2 | 13161-141B2 |
19.95 | 17.10 | 31.35 |
K562 erythroblastic leukemia response to hemin, day03, biol_rep3 | 13227-141I5 |
12.89 | 13.81 | 31.29 |
K562 erythroblastic leukemia response to hemin, day04, biol_rep1 | 13096-140C9 |
18.15 | 12.10 | 33.28 |
K562 erythroblastic leukemia response to hemin, day04, biol_rep2 | 13162-141B3 |
24.83 | 37.25 | 31.04 |
K562 erythroblastic leukemia response to hemin, day04, biol_rep3 | 13228-141I6 |
15.86 | 8.46 | 27.49 |
Keratinocyte - epidermal, donor1 | 11272-116H3 |
382.37 | 24.72 | 23.26 |
Keratinocyte - epidermal, donor2 | 11349-117G8 |
151.09 | 26.35 | 33.97 |
Keratinocyte - epidermal, donor3 | 11421-118F8 |
482.56 | 73.07 | 79.23 |
Keratinocyte - oral, donor1 | 11251-116E9 |
423.42 | 107.05 | 111.70 |
Keratocytes, donor1 | 11527-119I6 |
151.63 | 29.91 | 40.57 |
Keratocytes, donor2 | 11607-120I5 |
419.50 | 37.50 | 56.25 |
Keratocytes, donor3 | 11688-122I5 |
455.86 | 33.00 | 35.57 |
Krukenberg tumor cell line:HSKTC | 10687-109F3 |
90.11 | 37.36 | 24.18 |
Lens Epithelial Cells, donor1 | 11529-119I8 |
224.38 | 53.94 | 77.67 |
Lens Epithelial Cells, donor2 | 11609-120I7 |
136.09 | 60.32 | 52.71 |
Lens Epithelial Cells, donor3 | 11690-122I7 |
273.97 | 43.29 | 33.40 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1) | 12260-130A1 |
259.21 | 72.09 | 55.49 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1) | 12382-131E6 |
165.77 | 35.72 | 44.65 |
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 ) | 12504-133A2 |
219.27 | 40.45 | 49.11 |
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2) | 12261-130A2 |
165.62 | 39.79 | 58.07 |
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2) | 12383-131E7 |
155.69 | 35.30 | 39.71 |
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2) | 12505-133A3 |
216.92 | 38.81 | 50.89 |
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3) | 12262-130A3 |
128.04 | 25.03 | 41.04 |
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3) | 12384-131E8 |
150.17 | 27.05 | 38.93 |
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3) | 12506-133A4 |
190.15 | 36.74 | 42.08 |
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4) | 12263-130A4 |
192.62 | 43.90 | 57.75 |
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4) | 12385-131E9 |
190.78 | 34.71 | 45.95 |
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4) | 12507-133A5 |
147.38 | 24.62 | 34.81 |
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5) | 12264-130A5 |
164.80 | 35.54 | 44.95 |
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5) | 12386-131F1 |
154.09 | 28.86 | 40.07 |
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5) | 12508-133A6 |
170.86 | 36.67 | 38.73 |
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6) | 12265-130A6 |
152.13 | 28.33 | 45.58 |
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6) | 12387-131F2 |
159.61 | 28.99 | 35.23 |
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6) | 12509-133A7 |
178.42 | 37.15 | 39.71 |
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7) | 12266-130A7 |
142.50 | 28.30 | 44.76 |
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7) | 12388-131F3 |
161.96 | 27.24 | 35.73 |
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7) | 12510-133A8 |
156.33 | 25.64 | 33.36 |
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8) | 12267-130A8 |
148.88 | 39.28 | 60.62 |
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8) | 12389-131F4 |
204.40 | 43.09 | 45.51 |
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8) | 12511-133A9 |
194.07 | 33.61 | 44.05 |
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9) | 12268-130A9 |
195.44 | 30.59 | 61.17 |
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9) | 12390-131F5 |
190.34 | 38.11 | 40.62 |
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9) | 12512-133B1 |
155.94 | 29.47 | 37.29 |
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10) | 12269-130B1 |
201.55 | 35.77 | 49.53 |
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10) | 12391-131F6 |
192.48 | 37.44 | 42.71 |
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10) | 12513-133B2 |
153.11 | 32.34 | 35.84 |
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11) | 12270-130B2 |
145.37 | 27.14 | 38.77 |
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11) | 12392-131F7 |
195.50 | 37.05 | 43.00 |
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11) | 12514-133B3 |
156.85 | 29.86 | 34.57 |
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12) | 12271-130B3 |
155.49 | 33.69 | 43.31 |
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12) | 12393-131F8 |
198.90 | 38.30 | 43.24 |
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12) | 12515-133B4 |
147.81 | 29.29 | 33.41 |
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13) | 12272-130B4 |
151.17 | 35.38 | 36.99 |
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13) | 12394-131F9 |
203.60 | 39.87 | 41.08 |
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13) | 12516-133B5 |
217.93 | 37.79 | 47.59 |
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14) | 12273-130B5 |
178.14 | 39.82 | 43.73 |
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14) | 12395-131G1 |
160.95 | 20.36 | 37.81 |
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14) | 12517-133B6 |
133.36 | 27.39 | 31.12 |
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15) | 12274-130B6 |
184.07 | 34.02 | 44.41 |
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15) | 12396-131G2 |
178.69 | 28.42 | 44.10 |
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15) | 12518-133B7 |
152.55 | 23.78 | 30.61 |
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16) | 12275-130B7 |
261.73 | 65.46 | 43.44 |
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16) | 12397-131G3 |
145.22 | 20.23 | 30.22 |
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16) | 12519-133B8 |
146.79 | 28.94 | 40.28 |
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1 | 13031-139E7 |
292.32 | 20.39 | 20.39 |
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2 | 13097-140D1 |
154.19 | 18.41 | 15.34 |
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3 | 13163-141B4 |
185.56 | 23.75 | 10.39 |
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1 | 13032-139E8 |
165.44 | 11.42 | 22.43 |
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2 | 13098-140D2 |
166.69 | 16.18 | 16.88 |
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3 | 13164-141B5 |
141.96 | 12.14 | 17.75 |
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1 | 13033-139E9 |
171.58 | 13.40 | 17.00 |
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2 | 13099-140D3 |
172.47 | 17.84 | 21.41 |
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3 | 13165-141B6 |
267.13 | 22.17 | 22.17 |
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1 | 13034-139F1 |
296.94 | 35.48 | 29.96 |
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2 | 13100-140D4 |
326.83 | 34.21 | 33.31 |
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3 | 13166-141B7 |
268.26 | 20.73 | 19.65 |
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1 | 13035-139F2 |
187.95 | 18.49 | 21.05 |
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2 | 13101-140D5 |
257.23 | 32.46 | 20.11 |
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3 | 13167-141B8 |
238.54 | 24.65 | 19.99 |
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1 | 13036-139F3 |
199.17 | 21.39 | 17.83 |
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2 | 13102-140D6 |
308.69 | 29.88 | 25.35 |
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3 | 13168-141B9 |
318.75 | 32.88 | 26.07 |
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1 | 13037-139F4 |
180.39 | 19.02 | 31.29 |
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2 | 13103-140D7 |
217.72 | 20.39 | 28.54 |
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3 | 13169-141C1 |
320.28 | 37.28 | 27.28 |
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1 | 13038-139F5 |
312.49 | 23.82 | 28.87 |
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2 | 13104-140D8 |
171.04 | 26.79 | 19.58 |
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3 | 13170-141C2 |
277.53 | 23.51 | 25.55 |
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1 | 13039-139F6 |
275.61 | 24.21 | 26.90 |
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2 | 13105-140D9 |
274.42 | 23.24 | 27.66 |
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3 | 13171-141C3 |
181.69 | 19.44 | 15.20 |
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1 | 13040-139F7 |
194.72 | 23.23 | 18.81 |
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2 | 13106-140E1 |
187.66 | 20.72 | 13.82 |
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3 | 13172-141C4 |
182.28 | 14.20 | 19.19 |
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1 | 13041-139F8 |
173.80 | 19.25 | 21.51 |
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2 | 13107-140E2 |
228.91 | 27.90 | 19.69 |
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3 | 13173-141C5 |
144.15 | 12.20 | 18.53 |
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1 | 13042-139F9 |
214.72 | 14.36 | 21.54 |
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2 | 13108-140E3 |
215.11 | 23.15 | 21.66 |
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3 | 13174-141C6 |
188.77 | 13.75 | 17.09 |
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1 | 13043-139G1 |
232.60 | 24.12 | 23.26 |
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2 | 13109-140E4 |
221.78 | 22.26 | 21.41 |
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3 | 13175-141C7 |
222.56 | 23.32 | 21.32 |
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1 | 13044-139G2 |
181.60 | 16.89 | 20.51 |
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2 | 13110-140E5 |
161.40 | 19.20 | 19.91 |
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3 | 13176-141C8 |
185.26 | 20.28 | 16.50 |
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1 | 13045-139G3 |
164.24 | 11.81 | 19.32 |
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2 | 13111-140E6 |
157.57 | 14.81 | 14.14 |
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3 | 13177-141C9 |
189.28 | 18.52 | 17.04 |
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1 | 13046-139G4 |
379.12 | 36.05 | 27.91 |
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2 | 13112-140E7 |
127.99 | 16.92 | 14.81 |
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3 | 13178-141D1 |
184.87 | 18.41 | 18.81 |
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1 | 13048-139G6 |
146.83 | 10.18 | 22.53 |
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2 | 13114-140E9 |
178.60 | 22.23 | 19.93 |
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3 | 13180-141D3 |
198.30 | 20.72 | 22.69 |
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1 | 13049-139G7 |
155.25 | 14.11 | 22.58 |
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2 | 13115-140F1 |
162.91 | 18.10 | 13.07 |
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3 | 13181-141D4 |
157.27 | 18.02 | 16.22 |
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1 | 13050-139G8 |
135.97 | 18.93 | 17.21 |
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2 | 13116-140F2 |
199.51 | 18.26 | 24.49 |
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3 | 13182-141D5 |
144.68 | 19.55 | 18.77 |
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1 | 13051-139G9 |
168.89 | 15.83 | 17.15 |
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2 | 13117-140F3 |
158.27 | 15.57 | 18.16 |
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3 | 13183-141D6 |
155.34 | 16.63 | 21.44 |
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1 | 13052-139H1 |
198.48 | 13.98 | 20.69 |
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2 | 13118-140F4 |
151.48 | 16.34 | 21.20 |
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3 | 13184-141D7 |
199.03 | 17.74 | 23.14 |
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1 | 13053-139H2 |
156.46 | 10.63 | 15.70 |
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2 | 13119-140F5 |
165.81 | 17.78 | 18.74 |
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3 | 13185-141D8 |
197.18 | 23.06 | 21.47 |
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1 | 13054-139H3 |
167.10 | 10.94 | 15.19 |
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2 | 13120-140F6 |
199.21 | 11.76 | 16.60 |
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3 | 13186-141D9 |
164.16 | 16.72 | 17.48 |
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1 | 13055-139H4 |
170.93 | 12.39 | 9.30 |
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2 | 13121-140F7 |
166.88 | 9.67 | 15.72 |
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3 | 13187-141E1 |
180.63 | 17.75 | 16.16 |
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1 | 13056-139H5 |
138.60 | 11.73 | 15.46 |
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2 | 13122-140F8 |
180.45 | 7.47 | 22.41 |
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3 | 13188-141E2 |
186.67 | 15.94 | 18.51 |
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1 | 13057-139H6 |
171.89 | 16.98 | 16.27 |
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2 | 13123-140F9 |
208.27 | 9.08 | 19.86 |
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3 | 13189-141E3 |
176.81 | 12.48 | 12.06 |
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1 | 13058-139H7 |
155.83 | 13.31 | 11.75 |
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2 | 13124-140G1 |
155.33 | 6.26 | 15.45 |
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3 | 13190-141E4 |
134.74 | 15.80 | 12.08 |
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1 | 13059-139H8 |
163.92 | 12.71 | 24.75 |
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2 | 13125-140G2 |
172.15 | 9.62 | 13.90 |
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3 | 13191-141E5 |
153.56 | 19.40 | 19.80 |
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1 | 13060-139H9 |
158.77 | 7.34 | 22.94 |
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2 | 13126-140G3 |
135.14 | 7.11 | 18.67 |
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3 | 13192-141E6 |
178.37 | 19.38 | 20.52 |
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1 | 13061-139I1 |
141.11 | 13.80 | 18.41 |
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2 | 13127-140G4 |
195.89 | 9.85 | 17.51 |
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3 | 13193-141E7 |
146.55 | 15.15 | 22.72 |
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1 | 13062-139I2 |
215.50 | 16.64 | 15.60 |
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2 | 13128-140G5 |
196.94 | 11.94 | 20.56 |
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3 | 13194-141E8 |
178.76 | 12.47 | 12.47 |
Macrophage - monocyte derived, donor1 | 11232-116C8 |
666.20 | 45.81 | 40.34 |
Macrophage - monocyte derived, donor2 | 11313-117C8 |
1376.12 | 35.78 | 26.61 |
Macrophage - monocyte derived, donor3 | 11389-118C3 |
467.30 | 22.55 | 26.35 |
Mallassez-derived cells, donor1 (MZH3) | 12142-128E9 |
2317.91 | 134.88 | 81.25 |
Mallassez-derived cells, donor2 | 11929-125I3 |
536.99 | 85.88 | 76.69 |
Mallassez-derived cells, donor3 | 11930-125I4 |
789.87 | 114.11 | 136.07 |
Mammary Epithelial Cell, donor1 | 11273-116H4 |
814.29 | 77.62 | 74.83 |
Mammary Epithelial Cell, donor2 | 11350-117G9 |
564.33 | 71.52 | 90.34 |
Mammary Epithelial Cell, donor3 | 11422-118F9 |
193.80 | 26.19 | 22.20 |
Mast cell - stimulated, donor1 | 11487-119E2 |
216.26 | 25.76 | 29.15 |
Mast cell, donor1 | 11563-120D6 |
224.39 | 30.17 | 25.52 |
Mast cell, donor2 | 11565-120D8 |
439.22 | 58.54 | 36.26 |
Mast cell, donor3 | 11566-120D9 |
368.98 | 63.71 | 57.18 |
Mast cell, donor4 | 11567-120E1 |
401.74 | 43.61 | 33.33 |
Mast cell, expanded and stimulated, donor5 | 11940-126A5 |
1203.41 | 86.50 | 69.53 |
Mast cell, expanded and stimulated, donor8 | 11942-126A7 |
514.22 | 45.53 | 37.94 |
Mast cell, expanded, donor5 | 11939-126A4 |
545.39 | 65.62 | 69.41 |
Mast cell, expanded, donor8 | 11941-126A6 |
254.40 | 29.46 | 25.77 |
Melanocyte - dark, donor1 | 11502-119F8 |
216.51 | 78.90 | 70.44 |
Melanocyte - dark, donor2 | 11582-120F7 |
265.10 | 59.18 | 55.37 |
Melanocyte - dark, donor3 | 11663-122F7 |
192.19 | 52.23 | 37.09 |
Melanocyte - light, donor1 | 11274-116H5 |
54.77 | 8.70 | 10.11 |
Melanocyte - light, donor2 | 11351-117H1 |
44.36 | 8.19 | 10.24 |
Melanocyte - light, donor3 | 11423-118G1 |
66.78 | 6.07 | 6.07 |
Melanocyte, donor1 (MC+1) | 12641-134G4 |
152.23 | 50.81 | 68.93 |
Melanocyte, donor2 (MC+2) | 12739-135I3 |
197.67 | 33.35 | 43.84 |
Melanocyte, donor3 (MC+3) | 12837-137B2 |
80.09 | 25.71 | 29.73 |
Meningeal Cells, donor1 | 11493-119E8 |
344.39 | 47.39 | 77.04 |
Meningeal Cells, donor2 | 11573-120E7 |
140.41 | 23.77 | 50.18 |
Meningeal Cells, donor3 | 11654-122E7 |
581.03 | 106.44 | 83.13 |
Mesenchymal Stem Cells - Vertebral, donor1 | 11219-116B4 |
531.82 | 127.18 | 96.95 |
Mesenchymal Stem Cells - Wharton's Jelly, donor1 | 11548-120B9 |
347.18 | 32.10 | 25.36 |
Mesenchymal Stem Cells - adipose, donor1 | 11537-120A7 |
99.88 | 5.26 | 5.26 |
Mesenchymal Stem Cells - adipose, donor2 | 11617-122A6 |
170.06 | 20.93 | 31.40 |
Mesenchymal Stem Cells - adipose, donor3 | 11698-123A6 |
348.04 | 97.59 | 71.04 |
Mesenchymal Stem Cells - amniotic membrane, donor1 | 11547-120B8 |
721.49 | 36.00 | 32.61 |
Mesenchymal Stem Cells - amniotic membrane, donor2 | 11627-122B7 |
446.85 | 31.16 | 35.69 |
Mesenchymal Stem Cells - bone marrow, donor1 | 11536-120A6 |
288.54 | 41.97 | 51.20 |
Mesenchymal Stem Cells - bone marrow, donor2 | 11616-122A5 |
273.97 | 47.49 | 57.72 |
Mesenchymal Stem Cells - bone marrow, donor3 | 11697-123A5 |
194.58 | 28.85 | 30.69 |
Mesenchymal Stem Cells - bone marrow, donor4 | 11464-119B6 |
307.90 | 30.06 | 50.28 |
Mesenchymal Stem Cells - hepatic, donor1 | 11538-120A8 |
107.06 | 8.18 | 13.75 |
Mesenchymal Stem Cells - hepatic, donor2 | 11618-122A7 |
346.04 | 51.84 | 51.05 |
Mesenchymal Stem Cells - umbilical, donor1 | 11539-120A9 |
279.83 | 15.43 | 11.87 |
Mesenchymal Stem Cells - umbilical, donor2 | 11619-122A8 |
42.04 | 2.34 | 7.01 |
Mesenchymal Stem Cells - umbilical, donor3 | 11700-123A8 |
353.50 | 54.43 | 67.88 |
Mesenchymal stem cells - adipose, donor0 | 11217-116B2 |
551.52 | 93.22 | 104.56 |
Mesenchymal stem cells - hepatic, donor0 | 11218-116B3 |
325.55 | 46.28 | 49.41 |
Mesenchymal stem cells - umbilical, donor0 | 11214-116A8 |
354.14 | 78.37 | 102.32 |
Mesothelial Cells, donor1 | 11247-116E5 |
1297.50 | 25.46 | 31.03 |
Mesothelial Cells, donor2 | 12156-128G5 |
1378.79 | 51.55 | 33.53 |
Mesothelial Cells, donor3 | 11402-118D7 |
385.24 | 12.07 | 12.36 |
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1) | 12698-135D7 |
259.26 | 9.45 | 13.50 |
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2) | 12796-136F6 |
501.41 | 30.29 | 32.02 |
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3) | 12894-137H5 |
394.28 | 18.85 | 15.61 |
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1) | 12699-135D8 |
69.14 | 0.00 | 3.46 |
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2) | 12797-136F7 |
556.97 | 30.06 | 44.32 |
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3) | 12895-137H6 |
394.12 | 13.69 | 17.01 |
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1) | 12700-135D9 |
69.48 | 2.32 | 0.00 |
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2) | 12798-136F8 |
446.47 | 26.78 | 38.04 |
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3) | 12896-137H7 |
306.75 | 10.24 | 11.64 |
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1) | 12701-135E1 |
97.33 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2) | 12799-136F9 |
409.28 | 25.00 | 32.31 |
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3) | 12897-137H8 |
334.59 | 9.50 | 12.67 |
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1) | 12702-135E2 |
42.76 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2) | 12800-136G1 |
441.58 | 21.24 | 46.02 |
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3) | 12898-137H9 |
692.25 | 19.00 | 26.98 |
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1) | 12703-135E3 |
80.27 | 2.63 | 1.32 |
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2) | 12801-136G2 |
504.46 | 30.98 | 37.78 |
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3) | 12899-137I1 |
205.34 | 4.60 | 2.76 |
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1) | 12704-135E4 |
0.00 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2) | 12802-136G3 |
357.67 | 15.20 | 17.59 |
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3) | 12900-137I2 |
122.40 | 3.35 | 1.68 |
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1) | 12705-135E5 |
203.70 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2) | 12803-136G4 |
974.76 | 34.12 | 36.88 |
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3) | 12901-137I3 |
408.08 | 11.88 | 14.97 |
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1) | 12706-135E6 |
267.60 | 4.98 | 4.98 |
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2) | 12804-136G5 |
1844.96 | 42.37 | 46.51 |
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3) | 12902-137I4 |
686.34 | 14.72 | 18.30 |
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1) | 12707-135E7 |
986.33 | 28.54 | 32.00 |
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2) | 12805-136G6 |
1542.96 | 45.48 | 53.21 |
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3) | 12903-137I5 |
626.64 | 11.11 | 11.78 |
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1) | 12708-135E8 |
288.92 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2) | 12806-136G7 |
1504.43 | 28.91 | 33.07 |
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3) | 12904-137I6 |
488.20 | 10.65 | 4.06 |
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1) | 12709-135E9 |
369.51 | 4.97 | 3.31 |
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2) | 12807-136G8 |
1815.03 | 34.79 | 31.53 |
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3) | 12905-137I7 |
1063.40 | 11.47 | 12.94 |
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1) | 12710-135F1 |
507.00 | 8.72 | 2.18 |
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2) | 12808-136G9 |
1850.61 | 31.24 | 43.25 |
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3) | 12906-137I8 |
1726.59 | 14.81 | 15.21 |
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1) | 12711-135F2 |
601.96 | 12.34 | 5.48 |
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2) | 12809-136H1 |
1840.12 | 27.03 | 39.55 |
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3) | 12907-137I9 |
5982.27 | 26.95 | 0.00 |
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1) | 12712-135F3 |
509.63 | 8.15 | 6.12 |
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2) | 12810-136H2 |
4466.80 | 38.10 | 58.24 |
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3) | 12908-138A1 |
512.10 | 2.21 | 2.21 |
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1) | 12713-135F4 |
731.32 | 8.33 | 6.40 |
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2) | 12811-136H3 |
5586.11 | 51.07 | 62.23 |
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3) | 12909-138A2 |
837.16 | 6.96 | 9.05 |
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1) | 12714-135F5 |
592.25 | 0.00 | 6.63 |
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2) | 12812-136H4 |
5021.14 | 54.70 | 76.24 |
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3) | 12910-138A3 |
1053.78 | 11.82 | 5.69 |
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1) | 12715-135F6 |
697.41 | 6.75 | 6.75 |
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2) | 12813-136H5 |
6898.20 | 47.41 | 53.87 |
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3) | 12911-138A4 |
1628.43 | 10.81 | 11.64 |
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1) | 12716-135F7 |
689.97 | 4.66 | 5.83 |
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2) | 12814-136H6 |
2983.17 | 24.43 | 34.69 |
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3) | 12912-138A5 |
3008.55 | 19.20 | 25.46 |
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1) | 12717-135F8 |
548.63 | 0.00 | 0.00 |
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2) | 12815-136H7 |
3378.36 | 31.40 | 40.64 |
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3) | 12913-138A6 |
2563.88 | 18.21 | 18.78 |
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1) | 12718-135F9 |
1235.89 | 17.00 | 23.35 |
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2) | 12816-136H8 |
3841.62 | 37.84 | 52.87 |
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3) | 12914-138A7 |
2019.19 | 12.87 | 21.45 |
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1) | 12719-135G1 |
506.25 | 6.99 | 3.81 |
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2) | 12817-136H9 |
1796.96 | 17.61 | 23.75 |
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3) | 12915-138A8 |
2399.42 | 15.57 | 32.93 |
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1) | 12720-135G2 |
724.35 | 13.14 | 16.10 |
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2) | 12818-136I1 |
3361.91 | 37.90 | 65.30 |
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3) | 12916-138A9 |
3311.87 | 23.00 | 34.05 |
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1) | 12721-135G3 |
878.61 | 9.48 | 12.51 |
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2) | 12819-136I2 |
3089.37 | 40.63 | 50.85 |
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3) | 12917-138B1 |
4535.08 | 33.18 | 49.90 |
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1) | 12722-135G4 |
422.93 | 7.82 | 11.73 |
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2) | 12820-136I3 |
1959.69 | 37.64 | 47.34 |
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3) | 12918-138B2 |
2899.70 | 29.41 | 37.48 |
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1) | 12723-135G5 |
1557.08 | 41.21 | 30.50 |
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2) | 12821-136I4 |
1317.09 | 25.01 | 39.90 |
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h) | 13304-142I1 |
791.04 | 75.34 | 124.31 |
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h) | 13316-143A4 |
504.38 | 55.25 | 44.56 |
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h) | 13322-143B1 |
269.76 | 25.96 | 50.93 |
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h) | 13310-142I7 |
603.82 | 45.23 | 66.27 |
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h) | 13309-142I6 |
1113.37 | 65.43 | 63.26 |
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h) | 13321-143A9 |
599.77 | 31.66 | 37.25 |
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h) | 13327-143B6 |
297.42 | 21.03 | 33.42 |
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h) | 13315-143A3 |
489.27 | 24.77 | 36.76 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h) | 13305-142I2 |
554.08 | 61.07 | 76.57 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h) | 13317-143A5 |
232.07 | 16.21 | 38.31 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h) | 13323-143B2 |
221.32 | 24.92 | 39.21 |
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h) | 13311-142I8 |
404.45 | 45.11 | 52.89 |
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h) | 13306-142I3 |
1333.42 | 119.71 | 158.19 |
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h) | 13318-143A6 |
239.56 | 11.59 | 19.32 |
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h) | 13324-143B3 |
110.08 | 16.16 | 19.19 |
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h) | 13312-142I9 |
612.22 | 45.54 | 59.87 |
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h) | 13307-142I4 |
1796.40 | 202.93 | 249.24 |
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h) | 13319-143A7 |
1686.13 | 125.25 | 173.57 |
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h) | 13325-143B4 |
1790.55 | 174.92 | 230.80 |
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h) | 13313-143A1 |
1314.08 | 84.58 | 132.92 |
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h) | 13308-142I5 |
177.02 | 5.71 | 28.55 |
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h) | 13320-143A8 |
1572.50 | 97.87 | 101.14 |
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h) | 13326-143B5 |
1924.75 | 61.78 | 57.03 |
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h) | 13314-143A2 |
288.63 | 12.55 | 37.65 |
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1 | 11549-120C1 |
475.68 | 47.18 | 29.51 |
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2 | 11629-122B9 |
143.20 | 15.16 | 19.34 |
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1 | 13496-145C4 |
106.13 | 10.68 | 6.67 |
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2 | 13505-145D4 |
77.63 | 14.19 | 9.60 |
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3 | 13514-145E4 |
327.80 | 84.04 | 74.16 |
Myoblast differentiation to myotubes, day00, control donor1 | 13469-144I4 |
193.10 | 67.03 | 49.47 |
Myoblast differentiation to myotubes, day00, control donor2 | 13478-145A4 |
48.28 | 8.84 | 9.52 |
Myoblast differentiation to myotubes, day00, control donor3 | 13487-145B4 |
479.62 | 141.50 | 86.37 |
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1 | 13497-145C5 |
67.38 | 10.04 | 7.95 |
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2 | 13506-145D5 |
201.29 | 30.91 | 30.68 |
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3 | 13515-145E5 |
67.02 | 11.62 | 7.84 |
Myoblast differentiation to myotubes, day01, control donor1 | 13470-144I5 |
116.47 | 18.29 | 20.39 |
Myoblast differentiation to myotubes, day01, control donor2 | 13479-145A5 |
289.50 | 200.42 | 77.94 |
Myoblast differentiation to myotubes, day01, control donor3 | 13488-145B5 |
132.03 | 14.39 | 14.39 |
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1 | 13498-145C6 |
119.09 | 18.41 | 20.57 |
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2 | 13507-145D6 |
117.65 | 13.60 | 15.19 |
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3 | 13516-145E6 |
69.73 | 8.98 | 9.31 |
Myoblast differentiation to myotubes, day02, control donor1 | 13471-144I6 |
135.23 | 25.15 | 16.59 |
Myoblast differentiation to myotubes, day02, control donor2 | 13480-145A6 |
87.52 | 6.37 | 7.96 |
Myoblast differentiation to myotubes, day02, control donor3 | 13489-145B6 |
65.43 | 4.80 | 4.20 |
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1 | 13499-145C7 |
247.45 | 38.07 | 38.07 |
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2 | 13508-145D7 |
68.14 | 5.20 | 6.99 |
Myoblast differentiation to myotubes, day03, control donor1 | 13472-144I7 |
103.89 | 19.05 | 11.82 |
Myoblast differentiation to myotubes, day03, control donor2 | 13481-145A7 |
65.40 | 11.95 | 12.66 |
Myoblast differentiation to myotubes, day03, control donor3 | 13490-145B7 |
70.34 | 8.27 | 6.44 |
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1 | 13500-145C8 |
80.01 | 6.11 | 13.50 |
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2 | 13509-145D8 |
276.60 | 55.53 | 40.35 |
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3 | 13518-145E8 |
273.07 | 85.97 | 58.15 |
Myoblast differentiation to myotubes, day04, control donor1 | 13473-144I8 |
91.34 | 13.81 | 12.25 |
Myoblast differentiation to myotubes, day04, control donor2 | 13482-145A8 |
58.43 | 9.31 | 5.93 |
Myoblast differentiation to myotubes, day04, control donor3 | 13491-145B8 |
97.79 | 14.48 | 11.87 |
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1 | 13501-145C9 |
81.99 | 8.16 | 8.58 |
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2 | 13510-145D9 |
180.56 | 72.22 | 9.03 |
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3 | 13519-145E9 |
61.65 | 6.00 | 7.00 |
Myoblast differentiation to myotubes, day06, control donor1 | 13474-144I9 |
74.84 | 6.31 | 3.16 |
Myoblast differentiation to myotubes, day06, control donor2 | 13483-145A9 |
97.22 | 9.52 | 10.32 |
Myoblast differentiation to myotubes, day06, control donor3 | 13492-145B9 |
94.72 | 4.64 | 5.57 |
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1 | 13502-145D1 |
136.21 | 18.54 | 19.30 |
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2 | 13511-145E1 |
62.24 | 5.54 | 5.87 |
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3 | 13520-145F1 |
41.40 | 2.61 | 5.23 |
Myoblast differentiation to myotubes, day08, control donor1 | 13475-145A1 |
90.01 | 14.02 | 15.83 |
Myoblast differentiation to myotubes, day08, control donor2 | 13484-145B1 |
80.25 | 5.29 | 7.06 |
Myoblast differentiation to myotubes, day08, control donor3 | 13493-145C1 |
83.77 | 5.98 | 6.65 |
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1 | 13503-145D2 |
61.51 | 4.46 | 9.42 |
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2 | 13512-145E2 |
44.02 | 3.06 | 4.98 |
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3 | 13521-145F2 |
138.22 | 20.57 | 17.54 |
Myoblast differentiation to myotubes, day10, control donor1 | 13476-145A2 |
93.49 | 15.25 | 13.70 |
Myoblast differentiation to myotubes, day10, control donor2 | 13485-145B2 |
50.82 | 4.07 | 5.42 |
Myoblast differentiation to myotubes, day10, control donor3 | 13494-145C2 |
306.57 | 97.08 | 40.88 |
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1 | 13504-145D3 |
78.04 | 7.93 | 5.49 |
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2 | 13513-145E3 |
41.55 | 3.15 | 3.15 |
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3 | 13522-145F3 |
36.32 | 5.15 | 3.93 |
Myoblast differentiation to myotubes, day12, control donor1 | 13477-145A3 |
53.80 | 14.24 | 12.66 |
Myoblast differentiation to myotubes, day12, control donor2 | 13486-145B3 |
167.78 | 48.75 | 20.41 |
Myoblast differentiation to myotubes, day12, control donor3 | 13495-145C3 |
429.92 | 156.79 | 91.04 |
Myoblast, donor1 | 11241-116D8 |
1274.96 | 66.59 | 44.72 |
Myoblast, donor2 | 11322-117D8 |
529.14 | 42.58 | 29.92 |
Myoblast, donor3 | 11398-118D3 |
685.43 | 62.05 | 36.83 |
NK T cell leukemia cell line:KHYG-1 | 10777-110G3 |
536.45 | 48.60 | 61.00 |
Natural Killer Cells, donor1 | 11230-116C6 |
30.44 | 15.99 | 13.53 |
Natural Killer Cells, donor2 | 11311-117C6 |
21.11 | 8.75 | 10.86 |
Natural Killer Cells, donor3 | 11387-118C1 |
17.49 | 11.60 | 11.41 |
Neural stem cells, donor1 | 11275-116H6 |
154.25 | 46.82 | 25.77 |
Neural stem cells, donor2 | 11352-117H2 |
119.39 | 46.22 | 38.51 |
Neurons, donor1 | 11494-119E9 |
125.17 | 63.72 | 84.20 |
Neurons, donor2 | 11574-120E8 |
177.89 | 64.73 | 64.29 |
Neurons, donor3 | 11655-122E8 |
142.23 | 50.15 | 75.64 |
Neutrophils, donor1 | 11233-116C9 |
125.28 | 68.67 | 64.03 |
Neutrophils, donor2 | 11314-117C9 |
49.28 | 37.69 | 55.08 |
Neutrophils, donor3 | 11390-118C4 |
343.29 | 142.33 | 163.09 |
Nucleus Pulposus Cell, donor1 | 11252-116F1 |
389.10 | 38.35 | 23.15 |
Nucleus Pulposus Cell, donor2 | 11409-118E5 |
203.50 | 31.26 | 17.26 |
Nucleus Pulposus Cell, donor3 | 11462-119B4 |
215.19 | 23.46 | 38.31 |
Olfactory epithelial cells, donor1 | 11933-125I7 |
221.07 | 25.19 | 18.31 |
Olfactory epithelial cells, donor2 | 11934-125I8 |
627.18 | 48.34 | 29.38 |
Olfactory epithelial cells, donor3 | 11935-125I9 |
403.17 | 27.35 | 21.45 |
Olfactory epithelial cells, donor4 | 11936-126A1 |
185.74 | 32.82 | 27.08 |
Oligodendrocyte - precursors, donor1 | 11496-119F2 |
273.23 | 67.40 | 85.46 |
Osteoblast - differentiated, donor1 | 11276-116H7 |
172.92 | 19.14 | 12.55 |
Osteoblast - differentiated, donor2 | 11353-117H3 |
107.45 | 12.57 | 6.86 |
Osteoblast - differentiated, donor3 | 11425-118G3 |
140.90 | 17.38 | 9.31 |
Osteoblast, donor1 | 11277-116H8 |
133.87 | 20.33 | 15.05 |
Osteoblast, donor2 | 11354-117H4 |
249.32 | 58.99 | 45.65 |
Osteoblast, donor3 | 11426-118G4 |
121.57 | 22.04 | 25.24 |
Pancreatic stromal cells, donor1 | 11249-116E7 |
718.19 | 72.53 | 47.00 |
Pericytes, donor1 | 11491-119E6 |
246.45 | 15.24 | 18.25 |
Pericytes, donor2 | 11571-120E5 |
117.71 | 14.49 | 23.09 |
Pericytes, donor3 | 11652-122E5 |
343.63 | 42.93 | 49.03 |
Perineurial Cells, donor1 | 11499-119F5 |
332.51 | 92.34 | 78.10 |
Perineurial Cells, donor2 | 11579-120F4 |
354.06 | 83.27 | 57.05 |
Peripheral Blood Mononuclear Cells, donor1 | 11231-116C7 |
45.58 | 17.53 | 17.53 |
Peripheral Blood Mononuclear Cells, donor2 | 11312-117C7 |
27.67 | 13.71 | 15.18 |
Peripheral Blood Mononuclear Cells, donor3 | 11388-118C2 |
16.18 | 9.06 | 9.71 |
Placental Epithelial Cells, donor1 | 11278-116H9 |
532.86 | 56.68 | 64.81 |
Placental Epithelial Cells, donor2 | 11355-117H5 |
160.79 | 16.63 | 39.92 |
Placental Epithelial Cells, donor3 | 11427-118G5 |
84.81 | 14.53 | 22.38 |
Preadipocyte - breast donor2 (cytoplasmic fraction) | 14319-155D8 |
325.31 | 35.13 | 48.10 |
Preadipocyte - breast, donor1 | 11467-119B9 |
502.17 | 33.95 | 28.33 |
Preadipocyte - breast, donor2 (nuclear fraction) | 14320-155D9 |
240.17 | 36.29 | 22.45 |
Preadipocyte - breast, donor2 | 11328-117E5 |
313.86 | 39.85 | 34.45 |
Preadipocyte - omental, donor1 | 11468-119C1 |
1129.84 | 48.48 | 35.16 |
Preadipocyte - omental, donor2 | 11329-117E6 |
648.16 | 59.80 | 49.32 |
Preadipocyte - omental, donor3 | 11403-118D8 |
261.29 | 31.80 | 30.94 |
Preadipocyte - perirenal, donor1 | 11469-119C2 |
314.97 | 26.58 | 40.35 |
Preadipocyte - subcutaneous, donor1 | 11279-116I1 |
130.83 | 12.59 | 11.06 |
Preadipocyte - subcutaneous, donor2 | 11356-117H6 |
251.63 | 60.91 | 51.53 |
Preadipocyte - subcutaneous, donor3 | 11428-118G6 |
309.24 | 54.83 | 48.36 |
Preadipocyte - visceral, donor1 | 11280-116I2 |
749.84 | 95.48 | 70.42 |
Preadipocyte - visceral, donor2 | 11357-117H7 |
387.01 | 52.46 | 44.18 |
Preadipocyte - visceral, donor3 | 11429-118G7 |
374.29 | 52.35 | 63.43 |
Prostate Epithelial Cells (polarized), donor1 | 11253-116F2 |
466.13 | 50.99 | 39.83 |
Prostate Epithelial Cells, donor2 | 11331-117E8 |
434.81 | 25.05 | 25.32 |
Prostate Epithelial Cells, donor3 | 11404-118D9 |
185.37 | 23.82 | 44.83 |
Prostate Stromal Cells, donor1 | 11254-116F3 |
1298.58 | 60.03 | 36.68 |
Prostate Stromal Cells, donor2 | 11332-117E9 |
653.72 | 46.98 | 42.14 |
Prostate Stromal Cells, donor3 | 11405-118E1 |
803.03 | 37.64 | 32.22 |
Renal Cortical Epithelial Cells, donor1 | 11516-119H4 |
137.23 | 30.29 | 53.65 |
Renal Cortical Epithelial Cells, donor2 | 11596-120H3 |
204.26 | 71.18 | 83.66 |
Renal Epithelial Cells, donor1 | 11517-119H5 |
68.98 | 13.70 | 17.25 |
Renal Epithelial Cells, donor2 | 11597-120H4 |
96.03 | 29.88 | 32.72 |
Renal Epithelial Cells, donor3 | 11678-122H4 |
165.04 | 74.11 | 80.46 |
Renal Glomerular Endothelial Cells, donor1 | 11514-119H2 |
61.96 | 14.30 | 19.06 |
Renal Glomerular Endothelial Cells, donor2 | 11594-120H1 |
191.23 | 25.07 | 57.01 |
Renal Glomerular Endothelial Cells, donor3 | 11675-122H1 |
123.66 | 41.74 | 54.17 |
Renal Glomerular Endothelial Cells, donor4 | 11783-124B1 |
36.60 | 5.32 | 9.98 |
Renal Mesangial Cells, donor1 | 11518-119H6 |
199.84 | 40.94 | 41.38 |
Renal Mesangial Cells, donor2 | 11598-120H5 |
88.40 | 25.71 | 45.14 |
Renal Mesangial Cells, donor3 | 11679-122H5 |
73.24 | 14.15 | 18.59 |
Renal Proximal Tubular Epithelial Cell, donor1 | 11515-119H3 |
204.54 | 41.34 | 73.01 |
Renal Proximal Tubular Epithelial Cell, donor2 | 11595-120H2 |
107.95 | 23.61 | 44.28 |
Renal Proximal Tubular Epithelial Cell, donor3 | 11676-122H2 |
118.41 | 36.45 | 44.93 |
Retinal Pigment Epithelial Cells, donor0 | 11215-116A9 |
241.39 | 52.63 | 65.60 |
Retinal Pigment Epithelial Cells, donor1 | 11528-119I7 |
112.84 | 26.43 | 28.71 |
Retinal Pigment Epithelial Cells, donor2 | 11608-120I6 |
68.95 | 13.38 | 24.70 |
Retinal Pigment Epithelial Cells, donor3 | 11689-122I6 |
194.96 | 31.61 | 22.58 |
SABiosciences XpressRef Human Universal Total RNA, pool1 | 10002-101A5 |
191.37 | 24.86 | 24.32 |
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17) | 12697-135D6 |
204.59 | 44.67 | 80.41 |
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17) | 12795-136F5 |
294.45 | 64.39 | 121.08 |
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17) | 12893-137H4 |
131.67 | 35.38 | 95.71 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0) | 12662-134I7 |
392.42 | 98.30 | 153.95 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0) | 12760-136B6 |
258.39 | 77.06 | 90.57 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0) | 12858-137D5 |
522.00 | 167.53 | 151.80 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1) | 12663-134I8 |
454.37 | 157.04 | 202.69 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1) | 12761-136B7 |
306.86 | 89.62 | 116.66 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1) | 12859-137D6 |
387.61 | 121.34 | 146.31 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2) | 12664-134I9 |
239.86 | 65.99 | 100.22 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2) | 12762-136B8 |
328.57 | 96.66 | 121.93 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2) | 12860-137D7 |
530.05 | 147.29 | 147.29 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3) | 12665-135A1 |
266.83 | 72.73 | 113.76 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3) | 12763-136B9 |
305.09 | 106.24 | 125.45 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3) | 12861-137D8 |
396.07 | 115.06 | 146.92 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4) | 12666-135A2 |
237.82 | 48.18 | 101.71 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4) | 12764-136C1 |
254.43 | 83.29 | 99.96 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4) | 12862-137D9 |
431.43 | 143.56 | 123.27 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5) | 12667-135A3 |
216.84 | 52.82 | 98.47 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5) | 12765-136C2 |
235.47 | 85.27 | 110.77 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5) | 12863-137E1 |
326.35 | 106.75 | 122.98 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6) | 12668-135A4 |
245.52 | 68.67 | 117.69 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6) | 12766-136C3 |
296.84 | 102.87 | 125.58 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6) | 12864-137E2 |
275.32 | 93.31 | 104.08 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7) | 12669-135A5 |
265.47 | 61.26 | 107.57 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7) | 12767-136C4 |
223.07 | 80.32 | 89.28 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7) | 12865-137E3 |
314.31 | 100.07 | 124.92 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8) | 12670-135A6 |
373.62 | 75.72 | 166.05 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8) | 12768-136C5 |
283.93 | 90.67 | 106.55 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8) | 12866-137E4 |
422.79 | 128.15 | 164.63 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9) | 12671-135A7 |
317.88 | 78.59 | 126.69 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9) | 12769-136C6 |
352.39 | 104.41 | 125.87 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9) | 12867-137E5 |
240.43 | 83.76 | 100.68 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10) | 12672-135A8 |
277.24 | 67.97 | 116.15 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10) | 12770-136C7 |
249.99 | 75.61 | 95.54 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10) | 12868-137E6 |
271.84 | 78.85 | 103.72 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11) | 12673-135A9 |
346.11 | 74.62 | 143.57 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11) | 12771-136C8 |
249.78 | 75.72 | 79.28 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11) | 12869-137E7 |
391.87 | 119.68 | 143.81 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12) | 12674-135B1 |
240.48 | 57.26 | 104.99 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12) | 12772-136C9 |
243.39 | 84.48 | 98.24 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12) | 12870-137E8 |
217.77 | 94.36 | 95.96 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13) | 12675-135B2 |
186.11 | 52.82 | 90.56 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13) | 12773-136D1 |
252.63 | 83.34 | 119.53 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13) | 12871-137E9 |
191.87 | 88.28 | 81.62 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14) | 12676-135B3 |
271.41 | 64.13 | 108.39 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14) | 12774-136D2 |
292.77 | 77.21 | 74.06 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14) | 12872-137F1 |
188.28 | 67.39 | 35.96 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15) | 12677-135B4 |
354.92 | 70.25 | 112.47 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15) | 12775-136D3 |
592.98 | 219.06 | 134.34 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15) | 12873-137F2 |
344.37 | 139.94 | 111.95 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16) | 12678-135B5 |
426.78 | 70.83 | 129.00 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16) | 12776-136D4 |
172.58 | 52.70 | 62.88 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16) | 12874-137F3 |
161.45 | 82.97 | 76.38 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17) | 12679-135B6 |
324.82 | 54.55 | 75.10 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17) | 12777-136D5 |
197.44 | 56.14 | 65.95 |
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17) | 12875-137F4 |
260.82 | 114.79 | 120.80 |
Schwann Cells, donor1 | 11498-119F4 |
98.36 | 17.68 | 36.30 |
Schwann Cells, donor2 | 11578-120F3 |
193.94 | 71.45 | 85.06 |
Schwann Cells, donor3 | 11659-122F3 |
187.10 | 53.89 | 53.46 |
Sebocyte, donor1 | 11220-116B5 |
327.57 | 31.22 | 32.32 |
Sebocyte, donor2 | 11301-117B5 |
286.76 | 25.28 | 28.95 |
Sebocyte, donor3 | 11378-118B1 |
172.52 | 19.99 | 21.23 |
Sertoli Cells, donor1 | 11255-116F4 |
846.52 | 49.70 | 57.98 |
Sertoli Cells, donor2 | 11333-117F1 |
497.09 | 64.96 | 53.66 |
Skeletal Muscle Cells, donor1 | 11281-116I3 |
131.44 | 23.49 | 25.60 |
Skeletal Muscle Cells, donor2 | 11358-117H8 |
43.37 | 5.78 | 5.06 |
Skeletal Muscle Cells, donor3 | 11430-118G8 |
85.28 | 17.56 | 25.92 |
Skeletal Muscle Cells, donor4 | 11451-119A2 |
365.87 | 72.26 | 99.44 |
Skeletal Muscle Cells, donor5 | 11455-119A6 |
267.41 | 58.71 | 97.51 |
Skeletal Muscle Cells, donor6 | 11459-119B1 |
277.49 | 68.02 | 117.74 |
Skeletal Muscle Satellite Cells, donor1 | 11240-116D7 |
328.12 | 84.80 | 80.27 |
Skeletal Muscle Satellite Cells, donor2 | 11321-117D7 |
182.93 | 60.07 | 70.06 |
Skeletal Muscle Satellite Cells, donor3 | 11397-118D2 |
232.35 | 62.50 | 73.91 |
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1 | 11282-116I4 |
192.68 | 21.23 | 18.28 |
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2 | 11359-117H9 |
98.43 | 22.44 | 25.33 |
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3 | 11431-118G9 |
190.85 | 12.66 | 16.65 |
Skin - palm, donor1 | 10286-104F7 |
120.87 | 18.80 | 8.06 |
Small Airway Epithelial Cells donor2 (cytoplasmic fraction) | 14334-155F5 |
248.67 | 16.43 | 24.07 |
Small Airway Epithelial Cells donor2 (nuclear fraction) | 14335-155F6 |
89.15 | 4.91 | 36.81 |
Small Airway Epithelial Cells donor3 (cytoplasmic fraction) | 14316-155D5 |
236.16 | 18.95 | 26.10 |
Small Airway Epithelial Cells, donor1 | 11256-116F5 |
797.49 | 50.74 | 57.69 |
Small Airway Epithelial Cells, donor2 | 11334-117F2 |
244.88 | 24.33 | 22.51 |
Small Airway Epithelial Cells, donor3 (nuclear fraction) | 14317-155D6 |
259.87 | 26.85 | 19.03 |
Small Airway Epithelial Cells, donor3 | 11406-118E2 |
139.48 | 13.94 | 16.94 |
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction) | 14313-155D2 |
503.30 | 29.93 | 66.04 |
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction) | 14314-155D3 |
159.86 | 12.23 | 19.12 |
Smooth Muscle Cells - Aortic, donor0 | 11210-116A4 |
259.23 | 31.74 | 32.92 |
Smooth Muscle Cells - Aortic, donor1 | 11283-116I5 |
184.97 | 22.98 | 17.46 |
Smooth Muscle Cells - Aortic, donor2 | 11360-117I1 |
248.08 | 16.93 | 15.75 |
Smooth Muscle Cells - Aortic, donor3 | 11432-118H1 |
296.67 | 41.72 | 33.99 |
Smooth Muscle Cells - Bladder, donor1 | 11519-119H7 |
257.19 | 24.02 | 33.02 |
Smooth Muscle Cells - Brachiocephalic, donor1 | 11284-116I6 |
204.81 | 28.08 | 24.75 |
Smooth Muscle Cells - Brachiocephalic, donor2 | 11361-117I2 |
531.75 | 43.44 | 34.80 |
Smooth Muscle Cells - Brachiocephalic, donor3 | 11433-118H2 |
258.75 | 34.18 | 37.13 |
Smooth Muscle Cells - Brain Vascular, donor1 | 11234-116D1 |
432.06 | 81.40 | 56.65 |
Smooth Muscle Cells - Brain Vascular, donor2 | 11315-117D1 |
393.08 | 70.58 | 43.71 |
Smooth Muscle Cells - Brain Vascular, donor3 | 11391-118C5 |
250.70 | 33.31 | 44.70 |
Smooth Muscle Cells - Bronchial, donor1 | 11512-119G9 |
285.98 | 40.51 | 40.83 |
Smooth Muscle Cells - Bronchial, donor2 | 11592-120G8 |
128.78 | 22.53 | 25.57 |
Smooth Muscle Cells - Carotid, donor1 | 11285-116I7 |
691.52 | 34.60 | 24.25 |
Smooth Muscle Cells - Carotid, donor2 | 11362-117I3 |
55.09 | 12.24 | 12.24 |
Smooth Muscle Cells - Carotid, donor3 | 11434-118H3 |
99.66 | 13.83 | 23.36 |
Smooth Muscle Cells - Colonic, donor1 | 11239-116D6 |
564.68 | 66.51 | 67.25 |
Smooth Muscle Cells - Colonic, donor2 | 11320-117D6 |
289.93 | 41.11 | 57.04 |
Smooth Muscle Cells - Colonic, donor3 | 11396-118D1 |
308.79 | 49.44 | 64.97 |
Smooth Muscle Cells - Coronary Artery, donor1 | 11286-116I8 |
242.85 | 16.09 | 13.46 |
Smooth Muscle Cells - Coronary Artery, donor2 | 11363-117I4 |
331.99 | 30.18 | 16.17 |
Smooth Muscle Cells - Coronary Artery, donor3 | 11435-118H4 |
247.15 | 21.82 | 41.84 |
Smooth Muscle Cells - Esophageal, donor1 | 11508-119G5 |
162.51 | 22.53 | 32.77 |
Smooth Muscle Cells - Esophageal, donor2 | 11588-120G4 |
327.39 | 54.50 | 46.80 |
Smooth Muscle Cells - Internal Thoracic Artery, donor1 | 11287-116I9 |
506.53 | 37.84 | 21.94 |
Smooth Muscle Cells - Internal Thoracic Artery, donor2 | 11364-117I5 |
250.31 | 30.04 | 22.30 |
Smooth Muscle Cells - Internal Thoracic Artery, donor3 | 11436-118H5 |
152.16 | 11.47 | 30.79 |
Smooth Muscle Cells - Intestinal, donor1 | 11509-119G6 |
604.30 | 117.63 | 111.53 |
Smooth Muscle Cells - Prostate, donor1 | 11257-116F6 |
518.26 | 30.63 | 40.48 |
Smooth Muscle Cells - Prostate, donor2 | 11335-117F3 |
529.80 | 30.05 | 26.30 |
Smooth Muscle Cells - Prostate, donor3 | 11465-119B7 |
700.36 | 49.21 | 30.44 |
Smooth Muscle Cells - Pulmonary Artery, donor1 | 11288-117A1 |
696.57 | 49.00 | 44.33 |
Smooth Muscle Cells - Pulmonary Artery, donor2 | 11365-117I6 |
232.55 | 22.51 | 19.50 |
Smooth Muscle Cells - Pulmonary Artery, donor3 | 11437-118H6 |
60.73 | 6.46 | 19.38 |
Smooth Muscle Cells - Subclavian Artery, donor1 | 11289-117A2 |
322.76 | 40.00 | 33.02 |
Smooth Muscle Cells - Subclavian Artery, donor2 | 11366-117I7 |
234.77 | 37.87 | 25.24 |
Smooth Muscle Cells - Subclavian Artery, donor3 | 11438-118H7 |
178.32 | 11.91 | 16.30 |
Smooth Muscle Cells - Tracheal, donor1 | 11513-119H1 |
300.90 | 32.45 | 33.33 |
Smooth Muscle Cells - Tracheal, donor2 | 11593-120G9 |
384.46 | 89.30 | 68.89 |
Smooth Muscle Cells - Tracheal, donor3 | 11674-122G9 |
145.75 | 40.64 | 31.77 |
Smooth Muscle Cells - Umbilical Artery, donor1 | 11290-117A3 |
286.11 | 31.81 | 35.26 |
Smooth Muscle Cells - Umbilical Artery, donor2 | 11367-117I8 |
208.55 | 25.75 | 21.93 |
Smooth Muscle Cells - Umbilical Artery, donor3 | 11439-118H8 |
109.62 | 16.92 | 21.44 |
Smooth Muscle Cells - Umbilical Vein, donor1 | 11541-120B2 |
313.59 | 85.66 | 104.53 |
Smooth Muscle Cells - Umbilical Vein, donor2 | 11621-122B1 |
561.30 | 80.60 | 81.02 |
Smooth Muscle Cells - Umbilical Vein, donor3 | 11702-123B1 |
141.43 | 7.14 | 18.57 |
Smooth Muscle Cells - Umbilical artery, donor0 | 11212-116A6 |
236.10 | 26.42 | 23.49 |
Smooth Muscle Cells - Uterine, donor1 | 11258-116F7 |
478.35 | 33.81 | 44.19 |
Smooth Muscle Cells - Uterine, donor3 | 11466-119B8 |
954.39 | 149.51 | 104.74 |
Smooth muscle cells - airway, asthmatic, donor1 | 11960-126C7 |
455.97 | 18.85 | 21.57 |
Smooth muscle cells - airway, asthmatic, donor2 | 11961-126C8 |
562.49 | 28.30 | 37.02 |
Smooth muscle cells - airway, asthmatic, donor3 | 11962-126C9 |
1929.66 | 41.66 | 64.72 |
Smooth muscle cells - airway, asthmatic, donor4 | 11963-126D1 |
1147.72 | 20.48 | 32.34 |
Smooth muscle cells - airway, asthmatic, donor5 | 11964-126D2 |
1120.84 | 24.13 | 33.78 |
Smooth muscle cells - airway, asthmatic, donor6 | 11965-126D3 |
675.48 | 51.20 | 98.86 |
Smooth muscle cells - airway, control, donor1 | 11966-126D4 |
769.73 | 40.38 | 46.22 |
Smooth muscle cells - airway, control, donor2 | 11967-126D5 |
336.63 | 21.96 | 32.34 |
Smooth muscle cells - airway, control, donor3 | 11968-126D6 |
518.74 | 26.75 | 28.84 |
Smooth muscle cells - airway, control, donor4 | 11969-126D7 |
704.50 | 26.58 | 33.00 |
Synoviocyte, donor1 | 11291-117A4 |
343.04 | 45.45 | 37.54 |
Synoviocyte, donor2 | 11368-117I9 |
758.50 | 41.24 | 19.95 |
Synoviocyte, donor3 | 11440-118H9 |
323.72 | 20.33 | 14.75 |
Trabecular Meshwork Cells, donor1 | 11532-120A2 |
259.78 | 47.53 | 57.53 |
Trabecular Meshwork Cells, donor2 | 11612-122A1 |
152.62 | 9.91 | 15.86 |
Trabecular Meshwork Cells, donor3 | 11693-123A1 |
85.44 | 14.12 | 19.91 |
Tracheal Epithelial Cells, donor1 | 11292-117A5 |
403.73 | 44.37 | 48.17 |
Tracheal Epithelial Cells, donor2 | 11369-118A1 |
192.12 | 14.30 | 17.40 |
Tracheal Epithelial Cells, donor3 | 11441-118I1 |
124.27 | 12.03 | 17.75 |
Universal RNA - Human Normal Tissues Biochain, pool1 | 10007-101B4 |
180.35 | 27.31 | 24.11 |
Urethra, donor2 | 10319-105A4 |
34.17 | 10.79 | 12.59 |
Urothelial Cells, donor1 | 11520-119H8 |
431.43 | 43.04 | 52.07 |
Urothelial Cells, donor2 | 11600-120H7 |
241.94 | 35.65 | 44.46 |
Urothelial Cells, donor3 | 11681-122H7 |
124.00 | 18.57 | 23.84 |
Urothelial cells, donor0 | 11216-116B1 |
286.64 | 73.33 | 77.12 |
Whole blood (ribopure), donor090309, donation1 | 12179-129A1 |
94.32 | 19.58 | 59.62 |
Whole blood (ribopure), donor090309, donation2 | 12180-129A2 |
98.64 | 32.88 | 57.18 |
Whole blood (ribopure), donor090309, donation3 | 12181-129A3 |
45.86 | 12.32 | 25.33 |
Whole blood (ribopure), donor090325, donation1 | 12176-128I7 |
58.54 | 17.22 | 28.58 |
Whole blood (ribopure), donor090325, donation2 | 12177-128I8 |
74.37 | 15.11 | 23.82 |
Whole blood (ribopure), donor090612, donation1 | 12182-129A4 |
96.84 | 17.70 | 58.31 |
Whole blood (ribopure), donor090612, donation2 | 12183-129A5 |
81.68 | 19.27 | 55.99 |
Whole blood (ribopure), donor090612, donation3 | 12184-129A6 |
31.95 | 9.13 | 24.65 |
Wilms' tumor cell line:G-401 | 10809-111A8 |
272.13 | 47.00 | 46.26 |
Wilms' tumor cell line:HFWT | 10597-108E3 |
73.04 | 19.36 | 29.04 |
acantholytic squamous carcinoma cell line:HCC1806 | 10717-109I6 |
592.71 | 65.92 | 67.87 |
achilles tendon, donor2 | 10292-104G4 |
198.39 | 24.80 | 37.20 |
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1 | 10455-106G5 |
198.87 | 78.53 | 95.10 |
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6 | 10534-107G3 |
94.50 | 49.22 | 69.65 |
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL | 10429-106D6 |
185.07 | 55.44 | 55.79 |
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat | 10464-106H5 |
337.42 | 86.26 | 90.61 |
acute myeloid leukemia (FAB M0) cell line:KG-1 | 10827-111C8 |
204.35 | 64.65 | 118.90 |
acute myeloid leukemia (FAB M0) cell line:Kasumi-3 | 10789-110H6 |
581.15 | 84.38 | 96.01 |
acute myeloid leukemia (FAB M1) cell line:HYT-1 | 10828-111C9 |
84.11 | 14.97 | 26.13 |
acute myeloid leukemia (FAB M2) cell line:Kasumi-1 | 10788-110H5 |
357.80 | 84.60 | 122.50 |
acute myeloid leukemia (FAB M2) cell line:Kasumi-6 | 10792-110H9 |
182.54 | 44.10 | 71.87 |
acute myeloid leukemia (FAB M2) cell line:NKM-1 | 10765-110E9 |
161.92 | 45.82 | 42.32 |
acute myeloid leukemia (FAB M3) cell line:HL60 | 10829-111D1 |
253.18 | 71.58 | 107.64 |
acute myeloid leukemia (FAB M4) cell line:FKH-1 | 10830-111D2 |
198.93 | 66.31 | 70.21 |
acute myeloid leukemia (FAB M4) cell line:HNT-34 | 10831-111D3 |
374.83 | 102.71 | 175.22 |
acute myeloid leukemia (FAB M4eo) cell line:EoL-1 | 10832-111D4 |
487.25 | 145.50 | 208.67 |
acute myeloid leukemia (FAB M4eo) cell line:EoL-3 | 10833-111D5 |
166.29 | 51.43 | 66.92 |
acute myeloid leukemia (FAB M5) cell line:NOMO-1 | 10764-110E8 |
99.46 | 34.39 | 36.25 |
acute myeloid leukemia (FAB M5) cell line:P31/FUJ | 10770-110F5 |
143.94 | 68.68 | 127.49 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction) | 14298-155B5 |
65.38 | 7.37 | 13.81 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh) | 10399-106A3 |
387.45 | 70.41 | 72.97 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived) | 10400-106A4 |
394.58 | 86.14 | 72.49 |
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed) | 10405-106A9 |
424.12 | 87.62 | 79.67 |
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4 | 10834-111D6 |
197.12 | 47.22 | 77.29 |
acute myeloid leukemia (FAB M6) cell line:EEB | 10835-111D7 |
243.49 | 33.69 | 50.03 |
acute myeloid leukemia (FAB M6) cell line:F-36E | 10836-111D8 |
39.02 | 48.31 | 68.75 |
acute myeloid leukemia (FAB M6) cell line:F-36P | 10837-111D9 |
245.96 | 80.23 | 116.01 |
acute myeloid leukemia (FAB M7) cell line:M-MOK | 10699-109G6 |
119.50 | 26.60 | 47.54 |
acute myeloid leukemia (FAB M7) cell line:MKPL-1 | 10802-111A1 |
50.61 | 16.87 | 9.37 |
adenocarcinoma cell line:IM95m | 10796-110I4 |
290.14 | 40.51 | 38.39 |
adipose tissue, adult, pool1 | 10010-101C1 |
77.56 | 26.68 | 21.10 |
adipose, donor1 | 10184-103D4 |
140.74 | 193.52 | 208.18 |
adipose, donor2 | 10185-103D5 |
57.99 | 29.20 | 45.42 |
adipose, donor3 | 10186-103D6 |
121.71 | 49.28 | 43.29 |
adipose, donor4 | 10187-103D7 |
134.35 | 58.94 | 89.28 |
adrenal cortex adenocarcinoma cell line:SW-13 | 10810-111A9 |
65.50 | 21.15 | 18.46 |
adrenal gland, adult, pool1 | 10081-102A9 |
14.55 | 0.00 | 10.91 |
adult T-cell leukemia cell line:ATN-1 | 10421-106C7 |
543.50 | 120.73 | 134.74 |
alveolar cell carcinoma cell line:SW 1573 | 10708-109H6 |
418.04 | 98.26 | 108.98 |
amniotic membrane cells, donor1 | 12235-129G3 |
435.18 | 66.77 | 39.41 |
amniotic membrane cells, donor2 | 12236-129G4 |
195.09 | 55.11 | 55.11 |
amniotic membrane cells, donor3 | 12237-129G5 |
167.63 | 49.20 | 59.80 |
amygdala - adult, donor10196 | 10167-103B5 |
41.50 | 41.50 | 29.64 |
amygdala, adult, donor10252 | 10151-102I7 |
19.47 | 23.72 | 15.21 |
amygdala, newborn, donor10223 | 10360-105E9 |
86.18 | 20.98 | 25.82 |
anaplastic carcinoma cell line:8305C | 10428-106D5 |
243.33 | 41.51 | 42.27 |
anaplastic large cell lymphoma cell line:Ki-JK | 10795-110I3 |
945.37 | 127.52 | 202.53 |
anaplastic squamous cell carcinoma cell line:RPMI 2650 | 10805-111A4 |
108.90 | 32.07 | 24.38 |
aorta, adult, pool1 | 10052-101G7 |
45.90 | 16.87 | 13.53 |
appendix, adult | 10189-103D9 |
106.73 | 13.97 | 15.14 |
argyrophil small cell carcinoma cell line:TC-YIK | 10589-108D4 |
110.75 | 50.56 | 37.83 |
artery, adult | 10190-103E1 |
36.68 | 10.87 | 17.66 |
astrocytoma cell line:TM-31 | 10425-106D2 |
240.62 | 70.84 | 61.86 |
b cell line:RPMI1788 | 10427-106D4 |
650.72 | 57.40 | 72.27 |
basal cell carcinoma cell line:TE 354.T | 10702-109G9 |
569.04 | 62.15 | 39.40 |
bile duct carcinoma cell line:HuCCT1 | 10432-106D9 |
375.00 | 39.39 | 34.93 |
bile duct carcinoma cell line:TFK-1 | 10496-107C1 |
849.78 | 9.71 | 4.85 |
biphenotypic B myelomonocytic leukemia cell line:MV-4-11 | 10718-109I7 |
162.74 | 26.84 | 26.84 |
bladder, adult, pool1 | 10011-101C2 |
104.95 | 32.81 | 32.38 |
blood, adult, pool1 | 10053-101G8 |
31.00 | 26.58 | 15.50 |
bone marrow stromal cell line:StromaNKtert | 10686-109F2 |
1113.25 | 83.07 | 46.24 |
bone marrow, adult | 10192-103E3 |
155.21 | 13.50 | 28.34 |
brain, adult, donor1 | 10084-102B3 |
30.75 | 25.63 | 16.40 |
brain, adult, pool1 | 10012-101C3 |
44.43 | 32.52 | 25.39 |
brain, fetal, pool1 | 10085-102B4 |
48.09 | 29.39 | 37.40 |
breast carcinoma cell line:MCF7 | 10482-107A5 |
266.60 | 32.38 | 15.53 |
breast carcinoma cell line:MDA-MB-453 | 10419-106C5 |
187.98 | 25.21 | 22.47 |
breast, adult, donor1 | 10080-102A8 |
23.99 | 9.47 | 15.78 |
bronchial squamous cell carcinoma cell line:KNS-62 | 10760-110E4 |
599.24 | 34.55 | 23.25 |
bronchioalveolar carcinoma cell line:NCI-H358 | 10709-109H7 |
154.92 | 58.75 | 55.66 |
bronchioalveolar carcinoma cell line:NCI-H650 | 10715-109I4 |
113.04 | 72.06 | 137.90 |
bronchogenic carcinoma cell line:ChaGo-K-1 | 10710-109H8 |
239.42 | 30.50 | 30.99 |
carcinoid cell line:NCI-H1770 | 10703-109H1 |
53.13 | 56.89 | 119.42 |
carcinoid cell line:NCI-H727 | 10735-110B6 |
119.77 | 23.30 | 24.61 |
carcinoid cell line:SK-PN-DW | 10719-109I8 |
270.31 | 96.34 | 156.55 |
carcinosarcoma cell line:JHUCS-1 | 10642-109A3 |
77.19 | 35.14 | 38.06 |
caudate nucleus - adult, donor10196 | 10177-103C6 |
29.93 | 18.42 | 19.57 |
caudate nucleus, adult, donor10252 | 10164-103B2 |
16.57 | 19.41 | 14.89 |
caudate nucleus, adult, donor10258 | 10379-105H1 |
27.51 | 12.23 | 22.16 |
caudate nucleus, newborn, donor10223 | 10354-105E3 |
97.78 | 19.41 | 28.20 |
cerebellum - adult, donor10196 | 10173-103C2 |
11.65 | 17.48 | 23.31 |
cerebellum, adult, donor10252 | 10166-103B4 |
15.37 | 14.09 | 15.16 |
cerebellum, adult, pool1 | 10083-102B2 |
22.77 | 20.70 | 19.66 |
cerebellum, newborn, donor10223 | 10357-105E6 |
92.99 | 14.11 | 24.08 |
cerebral meninges, adult | 10188-103D8 |
39.33 | 30.76 | 20.93 |
cerebrospinal fluid, donor2 | 10294-104G6 |
89.90 | 10.23 | 14.62 |
cervical cancer cell line:D98-AH2 | 10552-107I3 |
539.33 | 108.56 | 97.20 |
cervical cancer cell line:ME-180 | 10553-107I4 |
957.68 | 77.72 | 60.16 |
cervix, adult, pool1 | 10013-101C4 |
174.91 | 25.83 | 19.42 |
cholangiocellular carcinoma cell line:HuH-28 | 10536-107G5 |
360.05 | 28.15 | 18.25 |
chondrosarcoma cell line:SW 1353 | 10700-109G7 |
90.13 | 28.74 | 13.06 |
choriocarcinoma cell line:BeWo | 10423-106C9 |
243.46 | 62.39 | 59.78 |
choriocarcinoma cell line:SCH | 10785-110H2 |
181.74 | 14.29 | 15.28 |
choriocarcinoma cell line:T3M-3 | 10618-108G6 |
106.26 | 10.91 | 13.99 |
chorionic membrane cells, donor1 | 12238-129G6 |
737.09 | 56.41 | 45.02 |
chorionic membrane cells, donor2 | 12239-129G7 |
262.20 | 63.04 | 53.89 |
chorionic membrane cells, donor3 | 12240-129G8 |
767.63 | 59.34 | 43.96 |
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3 | 10416-106C2 |
437.24 | 47.46 | 126.23 |
chronic myeloblastic leukemia (CML) cell line:KCL-22 | 10801-110I9 |
349.43 | 83.56 | 88.37 |
chronic myelogenous leukemia (CML) cell line:MEG-A2 | 10766-110F1 |
141.71 | 51.32 | 39.91 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1 | 10824-111C5 |
74.73 | 55.47 | 70.62 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2 | 10825-111C6 |
69.66 | 46.20 | 61.92 |
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3 | 10826-111C7 |
73.10 | 51.11 | 64.34 |
chronic myelogenous leukemia cell line:K562 | 10454-106G4 |
329.50 | 121.32 | 148.70 |
chronic myelogenous leukemia cell line:KU812 | 10409-106B4 |
248.38 | 69.85 | 48.48 |
clear cell carcinoma cell line:JHOC-5 | 10638-108I8 |
309.27 | 72.69 | 99.20 |
clear cell carcinoma cell line:TEN | 10636-108I6 |
213.93 | 52.40 | 33.83 |
colon carcinoma cell line:CACO-2 | 10513-107D9 |
692.63 | 75.96 | 71.57 |
colon carcinoma cell line:COLO-320 | 10420-106C6 |
158.87 | 83.24 | 117.83 |
colon, adult, donor1 | 10082-102B1 |
230.87 | 20.23 | 15.47 |
colon, adult, pool1 | 10014-101C5 |
339.70 | 29.61 | 19.15 |
colon, fetal, donor1 | 10070-101I7 |
131.01 | 14.83 | 17.30 |
common myeloid progenitor CMP, donor1 | 12130-128D6 |
18.33 | 13.75 | 13.75 |
common myeloid progenitor CMP, donor2 | 12134-128E1 |
851.25 | 150.22 | 75.11 |
cord blood derived cell line:COBL-a 24h infection(-C) | 10452-106G2 |
1928.77 | 39.94 | 27.20 |
cord blood derived cell line:COBL-a 24h infection | 10453-106G3 |
3338.30 | 45.73 | 29.73 |
cord blood derived cell line:COBL-a untreated | 10449-106F8 |
3906.15 | 61.34 | 38.36 |
corpus callosum, adult, pool1 | 10042-101F6 |
37.70 | 11.61 | 9.07 |
cruciate ligament, donor2 | 10295-104G7 |
165.34 | 19.45 | 21.88 |
diaphragm, fetal, donor1 | 10069-101I6 |
32.10 | 18.46 | 14.45 |
diencephalon, adult | 10193-103E4 |
44.16 | 24.72 | 21.60 |
diffuse large B-cell lymphoma cell line:CTB-1 | 10631-108I1 |
115.26 | 56.03 | 72.56 |
ductal cell carcinoma cell line:KLM-1 | 10438-106E6 |
313.11 | 51.54 | 66.93 |
ductal cell carcinoma cell line:MIA Paca2 | 10488-107B2 |
298.25 | 43.33 | 33.70 |
ductus deferens, adult | 10196-103E7 |
66.78 | 16.45 | 23.92 |
duodenum, fetal, donor1, tech_rep1 | 10071-101I8 |
142.58 | 23.04 | 14.40 |
duodenum, fetal, donor1, tech_rep2 | 10071-101I8 |
178.03 | 19.86 | 27.22 |
dura mater, adult, donor1 | 10041-101F5 |
116.70 | 24.45 | 14.87 |
embryonic kidney cell line: HEK293/SLAM infection, 24hr | 10451-106G1 |
174.55 | 32.42 | 27.76 |
embryonic kidney cell line: HEK293/SLAM untreated | 10450-106F9 |
360.10 | 77.38 | 54.02 |
embryonic pancreas cell line:1B2C6 | 10604-108F1 |
228.15 | 57.96 | 64.13 |
embryonic pancreas cell line:1C3D3 | 10605-108F2 |
283.64 | 73.56 | 98.68 |
embryonic pancreas cell line:1C3IKEI | 10606-108F3 |
326.66 | 50.94 | 67.00 |
embryonic pancreas cell line:2C6 | 10603-108E9 |
309.98 | 80.12 | 69.61 |
endometrial carcinoma cell line:OMC-2 | 10497-107C2 |
397.54 | 49.27 | 53.30 |
endometrial stromal sarcoma cell line:OMC-9 | 10448-106F7 |
203.16 | 60.90 | 80.11 |
endometrioid adenocarcinoma cell line:JHUEM-1 | 10643-109A4 |
297.50 | 50.66 | 51.14 |
epidermoid carcinoma cell line:A431 | 10426-106D3 |
778.67 | 75.59 | 51.36 |
epidermoid carcinoma cell line:Ca Ski | 10431-106D8 |
719.20 | 74.79 | 63.68 |
epididymis, adult | 10197-103E8 |
86.03 | 18.21 | 20.51 |
epithelioid sarcoma cell line:HS-ES-1 | 10443-106F2 |
242.16 | 59.96 | 54.82 |
epithelioid sarcoma cell line:HS-ES-2R | 10495-107B9 |
175.39 | 16.12 | 21.24 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1 | 10815-111B5 |
725.23 | 87.15 | 74.44 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2 | 10816-111B6 |
526.45 | 57.58 | 47.93 |
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3 | 10817-111B7 |
629.83 | 73.38 | 63.63 |
esophagus, adult, pool1 | 10015-101C6 |
813.11 | 36.63 | 33.02 |
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS | 10410-106B5 |
131.62 | 24.42 | 18.79 |
eye - muscle inferior rectus, donor1 | 10272-104E2 |
31.39 | 4.83 | 4.83 |
eye - muscle lateral, donor2 | 10298-104H1 |
46.29 | 8.42 | 8.42 |
eye - muscle medial, donor2 | 10299-104H2 |
16.37 | 8.93 | 4.46 |
eye - muscle superior, donor2 | 10297-104G9 |
85.99 | 16.05 | 17.20 |
eye - vitreous humor, donor1 | 10268-104D7 |
134.08 | 18.95 | 32.06 |
eye, fetal, donor1 | 10054-101G9 |
58.22 | 19.58 | 19.58 |
fibrosarcoma cell line:HT-1080 | 10758-110E2 |
198.36 | 51.55 | 71.16 |
fibrous histiocytoma cell line:GCT TIB-223 | 10711-109H9 |
165.72 | 41.79 | 60.78 |
frontal lobe, adult, pool1 | 10040-101F4 |
47.19 | 30.21 | 23.55 |
gall bladder carcinoma cell line:TGBC14TKB | 10470-106I2 |
507.42 | 73.56 | 50.74 |
gall bladder carcinoma cell line:TGBC2TKB | 10415-106C1 |
782.06 | 82.66 | 48.55 |
gall bladder, adult | 10198-103E9 |
99.23 | 17.87 | 11.35 |
gamma delta positive T cells, donor1 | 11937-126A2 |
32.75 | 23.08 | 31.14 |
gamma delta positive T cells, donor2 | 11938-126A3 |
31.75 | 21.66 | 23.90 |
gastric adenocarcinoma cell line:MKN1 | 10614-108G2 |
965.05 | 51.33 | 36.33 |
gastric adenocarcinoma cell line:MKN45 | 10612-108F9 |
111.60 | 20.70 | 25.72 |
gastric cancer cell line:AZ521 | 10549-107H9 |
247.08 | 49.51 | 46.40 |
gastric cancer cell line:GSS | 10560-108A2 |
112.57 | 56.74 | 96.10 |
gastrointestinal carcinoma cell line:ECC12 | 10615-108G3 |
115.83 | 21.02 | 24.90 |
giant cell carcinoma cell line:LU65 | 10487-107B1 |
436.93 | 138.72 | 180.60 |
giant cell carcinoma cell line:Lu99B | 10433-106E1 |
513.37 | 80.90 | 77.96 |
glassy cell carcinoma cell line:HOKUG | 10688-109F4 |
640.76 | 38.16 | 52.88 |
glioblastoma cell line:A172, tech_rep1 | 10444-106F3 |
272.22 | 43.70 | 41.48 |
glioblastoma cell line:A172, tech_rep2 | 10444-106F3 |
279.75 | 46.06 | 41.43 |
glioblastoma cell line:T98G | 10485-107A8 |
634.87 | 53.53 | 39.96 |
glioma cell line:GI-1 | 10413-106B8 |
164.30 | 55.35 | 45.10 |
globus pallidus - adult, donor10196 | 10175-103C4 |
51.02 | 13.12 | 15.31 |
globus pallidus, adult, donor10252 | 10161-103A8 |
31.49 | 15.13 | 14.65 |
globus pallidus, adult, donor10258 | 10367-105F7 |
39.71 | 6.85 | 13.69 |
globus pallidus, newborn, donor10223 | 10364-105F4 |
108.18 | 10.13 | 20.25 |
granulocyte macrophage progenitor, donor1 | 12131-128D7 |
36.71 | 9.79 | 4.89 |
granulocyte macrophage progenitor, donor2 | 12135-128E2 |
360.64 | 131.14 | 153.00 |
granulocyte macrophage progenitor, donor3 | 12139-128E6 |
449.49 | 167.25 | 78.40 |
granulosa cell tumor cell line:KGN | 10624-108H3 |
84.16 | 28.16 | 30.08 |
hIPS +CCl2, biol_rep1 | 14383-156B9 |
110.19 | 67.95 | 143.70 |
hIPS +CCl2, biol_rep2 | 14384-156C1 |
70.42 | 48.01 | 120.72 |
hIPS +CCl2, biol_rep3 | 14385-156C2 |
70.85 | 47.02 | 135.26 |
hIPS, biol_rep1 | 14380-156B6 |
40.24 | 37.37 | 156.66 |
hIPS, biol_rep2 | 14381-156B7 |
61.04 | 28.12 | 103.57 |
hIPS, biol_rep3 | 14382-156B8 |
29.79 | 12.14 | 28.69 |
hairy cell leukemia cell line:Mo | 10712-109I1 |
504.29 | 33.91 | 35.06 |
heart - mitral valve, adult | 10205-103F7 |
43.95 | 8.97 | 15.25 |
heart - pulmonic valve, adult | 10206-103F8 |
18.04 | 7.32 | 12.55 |
heart - tricuspid valve, adult | 10207-103F9 |
55.79 | 5.83 | 16.65 |
heart, adult, diseased post-infarction, donor1 | 10050-101G5 |
67.13 | 17.55 | 15.51 |
heart, adult, diseased, donor1 | 10051-101G6 |
13.63 | 9.37 | 10.65 |
heart, adult, pool1 | 10016-101C7 |
26.91 | 16.56 | 14.49 |
heart, fetal, pool1 | 10046-101G1 |
28.96 | 15.20 | 16.02 |
hepatic mesenchymal tumor cell line:LI90 | 10778-110G4 |
107.98 | 18.20 | 26.22 |
hepatoblastoma cell line:HuH-6 | 10633-108I3 |
58.27 | 17.84 | 5.95 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1 | 10818-111B8 |
289.28 | 45.97 | 34.03 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2 | 10819-111B9 |
351.26 | 56.92 | 34.96 |
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3 | 10820-111C1 |
308.11 | 46.38 | 36.88 |
hepatoma cell line:Li-7 | 10484-107A7 |
815.43 | 71.73 | 66.40 |
hereditary spherocytic anemia cell line:WIL2-NS | 10808-111A7 |
447.33 | 76.98 | 82.91 |
hippocampus - adult, donor10196 | 10169-103B7 |
36.91 | 24.60 | 25.55 |
hippocampus, adult, donor10252 | 10153-102I9 |
22.04 | 17.14 | 13.67 |
hippocampus, adult, donor10258 | 10374-105G5 |
14.94 | 11.95 | 25.40 |
hippocampus, newborn, donor10223 | 10363-105F3 |
75.43 | 19.03 | 25.73 |
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1 | 13421-144D1 |
526.12 | 219.72 | 387.57 |
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2 | 13425-144D5 |
177.70 | 76.97 | 112.31 |
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3 | 13429-144D9 |
223.17 | 81.75 | 137.87 |
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1 | 13422-144D2 |
44.55 | 41.73 | 71.61 |
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2 | 13426-144D6 |
38.22 | 63.78 | 81.34 |
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3 | 13430-144E1 |
45.17 | 58.84 | 82.38 |
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1 | 13423-144D3 |
70.07 | 38.83 | 55.18 |
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2 | 13427-144D7 |
67.00 | 40.50 | 48.69 |
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3 | 13431-144E2 |
117.20 | 31.28 | 47.55 |
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1 | 13424-144D4 |
249.11 | 76.96 | 61.09 |
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2 | 13428-144D8 |
168.43 | 58.02 | 58.18 |
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3 | 13432-144E3 |
269.99 | 59.92 | 65.98 |
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1 | 13433-144E4 |
162.59 | 67.60 | 95.77 |
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2 | 13437-144E8 |
192.10 | 85.98 | 141.98 |
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3 | 13441-144F3 |
549.83 | 145.75 | 308.08 |
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1 | 13434-144E5 |
50.40 | 43.91 | 52.88 |
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2 | 13438-144E9 |
32.71 | 36.63 | 49.71 |
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3 | 13442-144F4 |
108.45 | 88.96 | 114.95 |
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1 | 13435-144E6 |
41.63 | 28.07 | 47.10 |
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2 | 13439-144F1 |
66.84 | 47.75 | 46.38 |
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3 | 13443-144F5 |
71.73 | 38.53 | 52.00 |
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1 | 13436-144E7 |
152.36 | 49.97 | 38.87 |
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2 | 13440-144F2 |
135.57 | 47.61 | 47.32 |
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3 | 13444-144F6 |
137.21 | 32.58 | 40.06 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1 | 13445-144F7 |
155.92 | 60.78 | 95.14 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2 | 13449-144G2 |
135.22 | 54.49 | 81.59 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3 | 13453-144G6 |
345.02 | 89.01 | 152.30 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1 | 13446-144F8 |
57.74 | 44.71 | 54.92 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2 | 13450-144G3 |
45.93 | 29.46 | 44.66 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3 | 13454-144G7 |
53.26 | 28.14 | 52.66 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1 | 13447-144F9 |
58.95 | 23.79 | 27.92 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2 | 13451-144G4 |
67.08 | 27.89 | 33.21 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3 | 13455-144G8 |
91.58 | 28.48 | 44.89 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1 | 13448-144G1 |
133.45 | 35.28 | 39.37 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2 | 13452-144G5 |
110.55 | 37.86 | 32.56 |
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3 | 13456-144G9 |
193.57 | 29.91 | 43.02 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1 | 13457-144H1 |
114.47 | 55.79 | 78.97 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2 | 13461-144H5 |
263.38 | 79.33 | 163.56 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3 | 13465-144H9 |
153.66 | 44.88 | 95.12 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1 | 13458-144H2 |
28.42 | 26.89 | 37.59 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2 | 13462-144H6 |
182.18 | 364.36 | 504.25 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3 | 13466-144I1 |
60.23 | 52.29 | 97.30 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1 | 13459-144H3 |
55.28 | 29.55 | 41.59 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2 | 13463-144H7 |
54.28 | 24.97 | 36.91 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3 | 13467-144I2 |
57.65 | 29.54 | 37.72 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1 | 13460-144H4 |
103.82 | 27.45 | 47.74 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2 | 13464-144H8 |
151.68 | 53.90 | 45.50 |
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3 | 13468-144I3 |
135.24 | 37.18 | 50.38 |
immature langerhans cells, donor1 | 11904-125F5 |
2294.09 | 131.24 | 100.73 |
immature langerhans cells, donor2 | 11905-125F6 |
962.44 | 68.12 | 56.24 |
insula, adult, pool1 | 10039-101F3 |
46.75 | 30.76 | 22.81 |
keratoacanthoma cell line:HKA-1 | 10791-110H8 |
800.84 | 56.25 | 53.32 |
kidney, adult, pool1 | 10017-101C8 |
336.13 | 37.85 | 24.33 |
kidney, fetal, pool1 | 10045-101F9 |
123.15 | 16.06 | 13.86 |
large cell lung carcinoma cell line:IA-LM | 10509-107D5 |
181.50 | 52.83 | 52.97 |
large cell lung carcinoma cell line:NCI-H460 | 10839-111E2 |
1441.59 | 40.37 | 36.77 |
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF | 10692-109F8 |
372.69 | 47.53 | 71.93 |
left atrium, adult, donor1 | 10079-102A7 |
24.52 | 4.90 | 17.98 |
left ventricle, adult, donor1 | 10078-102A6 |
29.33 | 14.66 | 19.21 |
leiomyoblastoma cell line:G-402 | 10721-110A1 |
76.06 | 21.07 | 15.05 |
leiomyoma cell line:10964C | 10569-108B2 |
966.74 | 36.28 | 28.02 |
leiomyoma cell line:15242A | 10570-108B3 |
1072.29 | 48.91 | 42.93 |
leiomyoma cell line:15425 | 10571-108B4 |
550.22 | 45.89 | 33.75 |
leiomyosarcoma cell line:Hs 5.T | 10722-110A2 |
1098.44 | 101.59 | 31.75 |
lens epithelial cell line:SRA 01/04 | 10647-109A8 |
66.92 | 47.05 | 31.37 |
leukemia, chronic megakaryoblastic cell line:MEG-01 | 10752-110D5 |
116.88 | 59.86 | 52.06 |
liposarcoma cell line:KMLS-1 | 10782-110G8 |
190.73 | 34.52 | 33.12 |
liposarcoma cell line:SW 872 | 10726-110A6 |
165.46 | 39.60 | 34.60 |
liver, adult, pool1 | 10018-101C9 |
257.52 | 34.52 | 27.06 |
liver, fetal, pool1 | 10086-102B5 |
129.82 | 8.47 | 16.93 |
locus coeruleus - adult, donor10196 | 10182-103D2 |
45.06 | 11.96 | 12.83 |
locus coeruleus, adult, donor10252 | 10165-103B3 |
45.58 | 21.22 | 15.69 |
locus coeruleus, adult, donor10258 | 10375-105G6 |
75.33 | 13.54 | 15.80 |
locus coeruleus, newborn, donor10223 | 10362-105F2 |
165.30 | 24.40 | 29.86 |
lung adenocarcinoma cell line:A549 | 10499-107C4 |
1231.85 | 22.97 | 21.04 |
lung adenocarcinoma cell line:PC-14 | 10408-106B3 |
910.02 | 62.05 | 59.29 |
lung adenocarcinoma, papillary cell line:NCI-H441 | 10742-110C4 |
142.23 | 40.99 | 35.46 |
lung, adult, pool1 | 10019-101D1 |
217.00 | 33.43 | 26.93 |
lung, fetal, donor1 | 10068-101I5 |
107.31 | 15.70 | 30.82 |
lung, right lower lobe, adult, donor1 | 10075-102A3 |
119.59 | 14.66 | 14.66 |
lymph node, adult, donor1 | 10077-102A5 |
63.90 | 9.47 | 14.20 |
lymphangiectasia cell line:DS-1 | 10727-110A7 |
122.96 | 41.42 | 66.85 |
lymphoma, malignant, hairy B-cell cell line:MLMA | 10775-110G1 |
72.60 | 61.88 | 68.67 |
malignant trichilemmal cyst cell line:DJM-1 | 10412-106B7 |
666.85 | 85.80 | 71.36 |
mature adipocyte, donor1 | 12231-129F8 |
108.78 | 24.42 | 17.32 |
mature adipocyte, donor2 | 12232-129F9 |
185.32 | 40.05 | 26.15 |
mature adipocyte, donor3 | 12233-129G1 |
196.05 | 34.85 | 28.45 |
mature adipocyte, donor4 | 12234-129G2 |
138.72 | 34.22 | 26.32 |
maxillary sinus tumor cell line:HSQ-89 | 10414-106B9 |
625.19 | 56.23 | 30.50 |
medial frontal gyrus - adult, donor10196 | 10170-103B8 |
39.48 | 31.58 | 42.87 |
medial frontal gyrus, adult, donor10252 | 10150-102I6 |
18.76 | 18.76 | 13.06 |
medial frontal gyrus, adult, donor10258 | 10368-105F8 |
44.48 | 40.35 | 40.35 |
medial frontal gyrus, newborn, donor10223 | 10352-105E1 |
251.20 | 124.53 | 101.93 |
medial temporal gyrus - adult, donor10196 | 10183-103D3 |
45.23 | 41.68 | 30.88 |
medial temporal gyrus, adult, donor10252 | 10156-103A3 |
19.95 | 21.65 | 17.40 |
medial temporal gyrus, adult, donor10258, tech_rep1 | 10376-105G7 |
26.97 | 21.19 | 23.12 |
medial temporal gyrus, adult, donor10258, tech_rep2 | 10376-105G7 |
86.12 | 114.83 | 100.48 |
medial temporal gyrus, newborn, donor10223 | 10353-105E2 |
103.01 | 34.82 | 30.87 |
medulla oblongata - adult, donor10196 | 10174-103C3 |
49.32 | 11.68 | 18.82 |
medulla oblongata, adult, donor10252 | 10155-103A2 |
30.96 | 12.38 | 10.68 |
medulla oblongata, adult, pool1 | 10038-101F2 |
55.42 | 15.84 | 13.63 |
medulla oblongata, newborn, donor10223 | 10361-105F1 |
91.66 | 12.15 | 16.66 |
medulloblastoma cell line:D283 Med | 10838-111E1 |
56.46 | 44.28 | 81.70 |
medulloblastoma cell line:ONS-76 | 10759-110E3 |
157.00 | 39.13 | 34.73 |
melanoma cell line:COLO 679 | 10514-107E1 |
129.08 | 15.09 | 13.94 |
melanoma cell line:G-361 | 10465-106H6 |
261.69 | 72.21 | 70.85 |
meningioma cell line:HKBMM | 10691-109F7 |
292.70 | 58.61 | 60.06 |
merkel cell carcinoma cell line:MKL-1 | 10843-111E6 |
189.45 | 70.49 | 89.88 |
merkel cell carcinoma cell line:MS-1 | 10844-111E7 |
442.49 | 99.54 | 96.43 |
mesenchymal precursor cell - adipose, donor1 | 11747-123G1 |
396.78 | 63.98 | 58.92 |
mesenchymal precursor cell - adipose, donor2 | 11748-123G2 |
302.48 | 39.45 | 47.63 |
mesenchymal precursor cell - adipose, donor3 | 11749-123G3 |
568.56 | 47.21 | 58.80 |
mesenchymal precursor cell - bone marrow, donor1 | 11750-123G4 |
314.95 | 44.81 | 51.27 |
mesenchymal precursor cell - bone marrow, donor2 | 11751-123G5 |
282.11 | 39.86 | 36.40 |
mesenchymal precursor cell - bone marrow, donor3 | 11840-124H4 |
544.16 | 38.17 | 39.56 |
mesenchymal precursor cell - cardiac, donor1 | 11752-123G6 |
1025.52 | 57.33 | 61.62 |
mesenchymal precursor cell - cardiac, donor2 | 11753-123G7 |
534.82 | 38.07 | 34.85 |
mesenchymal precursor cell - cardiac, donor3 | 11754-123G8 |
393.53 | 78.92 | 70.17 |
mesenchymal precursor cell - cardiac, donor4 | 11755-123G9 |
751.77 | 74.54 | 65.36 |
mesenchymal precursor cell - ovarian cancer left ovary, donor1 | 11756-123H1 |
222.21 | 50.93 | 68.71 |
mesenchymal precursor cell - ovarian cancer left ovary, donor2 | 11833-124G6 |
167.64 | 23.71 | 28.65 |
mesenchymal precursor cell - ovarian cancer left ovary, donor3 | 11760-123H5 |
239.11 | 55.35 | 62.41 |
mesenchymal precursor cell - ovarian cancer left ovary, donor4 | 11836-124G9 |
805.68 | 72.26 | 85.18 |
mesenchymal precursor cell - ovarian cancer metastasis, donor1 | 11758-123H3 |
487.14 | 66.97 | 73.09 |
mesenchymal precursor cell - ovarian cancer metastasis, donor2 | 11835-124G8 |
186.92 | 23.72 | 31.63 |
mesenchymal precursor cell - ovarian cancer metastasis, donor3 | 11762-123H7 |
486.73 | 46.45 | 66.73 |
mesenchymal precursor cell - ovarian cancer metastasis, donor4 | 11838-124H2 |
804.58 | 24.40 | 28.04 |
mesenchymal precursor cell - ovarian cancer right ovary, donor1 | 11757-123H2 |
910.02 | 68.81 | 86.01 |
mesenchymal precursor cell - ovarian cancer right ovary, donor2 | 11759-123H4 |
308.29 | 55.14 | 56.19 |
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02) | 11761-123H6 |
286.31 | 49.98 | 63.63 |
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G) | 11842-124H6 |
353.07 | 43.44 | 76.58 |
mesenchymal precursor cell - ovarian cancer right ovary, donor4 | 11837-124H1 |
205.46 | 30.33 | 42.07 |
mesenchymal stem cell line:Hu5/E18 | 10568-108B1 |
275.34 | 73.68 | 78.73 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1 | 13229-141I7 |
441.60 | 45.21 | 51.15 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2 | 13230-141I8 |
479.34 | 59.09 | 47.06 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3 | 13231-141I9 |
369.08 | 54.71 | 44.50 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1 | 13232-142A1 |
379.25 | 50.53 | 33.58 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2 | 13233-142A2 |
459.65 | 60.02 | 52.25 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3 | 13234-142A3 |
433.22 | 60.58 | 37.57 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1 | 13235-142A4 |
371.75 | 44.80 | 34.97 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2 | 13236-142A5 |
388.78 | 47.27 | 40.31 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3 | 13237-142A6 |
483.04 | 96.61 | 96.61 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1 | 13238-142A7 |
597.60 | 79.89 | 66.62 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2 | 13239-142A8 |
409.61 | 51.98 | 43.50 |
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3 | 13240-142A9 |
456.19 | 59.37 | 41.58 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1 | 13241-142B1 |
425.33 | 67.47 | 51.33 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2 | 13242-142B2 |
406.82 | 46.66 | 32.89 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3 | 13243-142B3 |
424.93 | 50.76 | 40.94 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1 | 13244-142B4 |
450.61 | 56.70 | 52.41 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2 | 13245-142B5 |
525.01 | 46.48 | 51.95 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3 | 13246-142B6 |
511.33 | 20.66 | 46.48 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1 | 13247-142B7 |
511.54 | 51.32 | 56.19 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2 | 13248-142B8 |
531.07 | 53.83 | 56.74 |
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3 | 13249-142B9 |
535.74 | 49.04 | 50.11 |
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1 | 13250-142C1 |
481.67 | 40.89 | 35.98 |
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2 | 13251-142C2 |
425.26 | 43.15 | 39.65 |
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3 | 13252-142C3 |
512.09 | 54.57 | 33.58 |
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1 | 13253-142C4 |
535.48 | 43.71 | 44.71 |
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2 | 13254-142C5 |
491.02 | 28.60 | 47.67 |
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3 | 13255-142C6 |
464.29 | 47.44 | 45.66 |
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1 | 13256-142C7 |
522.72 | 67.02 | 60.92 |
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2 | 13257-142C8 |
324.63 | 27.05 | 0.00 |
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3 | 13258-142C9 |
521.27 | 62.70 | 55.10 |
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1 | 13259-142D1 |
328.00 | 30.35 | 30.35 |
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2 | 13260-142D2 |
322.38 | 36.54 | 34.39 |
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3 | 13261-142D3 |
335.31 | 27.94 | 47.90 |
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1 | 13262-142D4 |
292.73 | 24.11 | 17.22 |
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2 | 13263-142D5 |
232.26 | 28.52 | 29.75 |
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3 | 13264-142D6 |
259.78 | 33.37 | 32.57 |
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1 | 13265-142D7 |
184.52 | 22.40 | 22.99 |
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2 | 13266-142D8 |
169.26 | 27.12 | 24.94 |
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3 | 13267-142D9 |
208.52 | 30.74 | 34.75 |
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1 | 13268-142E1 |
214.06 | 21.29 | 29.57 |
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2 | 13269-142E2 |
233.69 | 23.11 | 17.98 |
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3 | 13270-142E3 |
198.26 | 26.16 | 24.78 |
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1 | 13271-142E4 |
113.31 | 22.76 | 30.68 |
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2 | 13272-142E5 |
105.42 | 29.16 | 32.52 |
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3 | 13273-142E6 |
122.76 | 27.35 | 19.72 |
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1 | 13274-142E7 |
108.40 | 22.97 | 34.25 |
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2 | 13275-142E8 |
113.39 | 28.35 | 41.43 |
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3 | 13276-142E9 |
93.76 | 24.07 | 30.41 |
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1 | 13277-142F1 |
226.98 | 26.10 | 41.27 |
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2 | 13278-142F2 |
320.85 | 22.59 | 36.15 |
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3 | 13279-142F3 |
219.10 | 19.77 | 25.53 |
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1 | 13280-142F4 |
328.99 | 39.88 | 35.32 |
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2 | 13281-142F5 |
204.11 | 28.56 | 33.10 |
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3 | 13282-142F6 |
164.00 | 30.56 | 31.58 |
mesodermal tumor cell line:HIRS-BM | 10696-109G3 |
161.71 | 26.31 | 17.80 |
mesothelioma cell line:ACC-MESO-1 | 10493-107B7 |
314.91 | 62.37 | 87.17 |
mesothelioma cell line:ACC-MESO-4 | 10494-107B8 |
211.75 | 43.32 | 42.63 |
mesothelioma cell line:Mero-14, tech_rep1 | 10849-111F3 |
730.78 | 25.64 | 64.10 |
mesothelioma cell line:Mero-14, tech_rep2 | 10849-111F3 |
2551.70 | 160.39 | 111.59 |
mesothelioma cell line:Mero-25 | 10850-111F4 |
212.20 | 26.55 | 44.94 |
mesothelioma cell line:Mero-41 | 10851-111F5 |
502.40 | 39.36 | 59.16 |
mesothelioma cell line:Mero-48a | 10852-111F6 |
226.08 | 36.98 | 48.71 |
mesothelioma cell line:Mero-82 | 10853-111F7 |
250.45 | 27.86 | 38.63 |
mesothelioma cell line:Mero-83 | 10854-111F8 |
402.74 | 36.43 | 39.83 |
mesothelioma cell line:Mero-84 | 10855-111F9 |
261.87 | 27.05 | 68.25 |
mesothelioma cell line:Mero-95 | 10856-111G1 |
266.67 | 20.29 | 22.57 |
mesothelioma cell line:NCI-H2052 | 10847-111F1 |
263.71 | 29.65 | 33.13 |
mesothelioma cell line:NCI-H226 | 10846-111E9 |
376.64 | 28.05 | 38.73 |
mesothelioma cell line:NCI-H2452 | 10848-111F2 |
525.28 | 57.40 | 71.23 |
mesothelioma cell line:NCI-H28 | 10845-111E8 |
1111.76 | 66.42 | 98.22 |
mesothelioma cell line:No36 | 10857-111G2 |
217.58 | 42.08 | 56.11 |
mesothelioma cell line:ONE58 | 10858-111G3 |
991.96 | 58.80 | 102.96 |
migratory langerhans cells, donor1 | 11901-125F2 |
8921.71 | 191.35 | 177.91 |
migratory langerhans cells, donor2 | 11902-125F3 |
8845.55 | 92.32 | 86.58 |
migratory langerhans cells, donor3 | 11903-125F4 |
11418.19 | 177.33 | 148.43 |
mixed mullerian tumor cell line:HTMMT | 10689-109F5 |
122.10 | 55.17 | 81.95 |
mucinous adenocarcinoma cell line:JHOM-1 | 10648-109A9 |
783.32 | 264.71 | 267.68 |
mucinous cystadenocarcinoma cell line:MCAS | 10784-110H1 |
213.77 | 21.42 | 26.26 |
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162 | 10744-110C6 |
551.85 | 38.63 | 49.67 |
myelodysplastic syndrome cell line:SKM-1 | 10772-110F7 |
469.00 | 104.04 | 64.31 |
myeloma cell line:PCM6 | 10474-106I6 |
357.38 | 32.42 | 39.93 |
myxofibrosarcoma cell line:MFH-ino | 10600-108E6 |
204.95 | 23.84 | 29.93 |
myxofibrosarcoma cell line:NMFH-1 | 10684-109E9 |
280.87 | 85.91 | 76.30 |
nasal epithelial cells, donor1, tech_rep1 | 12226-129F3 |
530.05 | 61.39 | 100.62 |
nasal epithelial cells, donor1, tech_rep2 | 12226-129F3 |
763.13 | 95.68 | 134.14 |
nasal epithelial cells, donor2 | 12227-129F4 |
544.81 | 51.34 | 57.96 |
neuroblastoma cell line:CHP-134 | 10508-107D4 |
130.90 | 54.29 | 51.30 |
neuroblastoma cell line:NB-1 | 10539-107G8 |
111.32 | 110.75 | 96.54 |
neuroblastoma cell line:NBsusSR | 10607-108F4 |
63.48 | 39.23 | 28.05 |
neuroblastoma cell line:NH-12 | 10555-107I6 |
64.29 | 67.65 | 81.06 |
neuroectodermal tumor cell line:FU-RPNT-1 | 10637-108I7 |
156.57 | 29.65 | 16.84 |
neuroectodermal tumor cell line:FU-RPNT-2 | 10663-109C6 |
81.25 | 32.15 | 21.38 |
neuroectodermal tumor cell line:TASK1 | 10774-110F9 |
129.61 | 30.39 | 29.18 |
neuroepithelioma cell line:SK-N-MC | 10728-110A8 |
92.19 | 27.97 | 27.97 |
neurofibroma cell line:Hs 53.T | 10729-110A9 |
224.38 | 33.54 | 27.15 |
neutrophil PMN, donor1 | 12133-128D9 |
59.50 | 0.00 | 0.00 |
neutrophil PMN, donor2 | 12137-128E4 |
278.89 | 13.28 | 106.25 |
neutrophil PMN, donor3 | 12141-128E8 |
265.18 | 94.71 | 142.06 |
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK | 10430-106D7 |
42.62 | 40.93 | 44.31 |
non-small cell lung cancer cell line:NCI-H1385 | 10730-110B1 |
2605.65 | 394.65 | 347.42 |
normal embryonic palatal mesenchymal cell line:HEPM | 10813-111B3 |
358.44 | 43.28 | 34.95 |
normal intestinal epithelial cell line:FHs 74 Int | 10812-111B2 |
877.63 | 45.72 | 39.41 |
nucleus accumbens, adult, pool1 | 10037-101F1 |
40.12 | 23.90 | 15.94 |
occipital cortex - adult, donor10196 | 10172-103C1 |
30.91 | 12.36 | 30.91 |
occipital cortex, adult, donor10252 | 10163-103B1 |
23.08 | 9.93 | 15.57 |
occipital cortex, newborn, donor10223 | 10355-105E4 |
59.32 | 26.20 | 27.30 |
occipital lobe, adult, donor1 | 10076-102A4 |
35.42 | 27.03 | 25.45 |
occipital lobe, fetal, donor1 | 10073-102A1 |
63.51 | 33.04 | 43.77 |
occipital pole, adult, pool1 | 10036-101E9 |
18.45 | 11.83 | 13.72 |
olfactory region, adult | 10195-103E6 |
35.34 | 26.17 | 20.63 |
optic nerve, donor1 | 10277-104E7 |
40.02 | 20.01 | 10.01 |
oral squamous cell carcinoma cell line:Ca9-22 | 10434-106E2 |
629.23 | 48.18 | 41.46 |
oral squamous cell carcinoma cell line:HO-1-u-1 | 10550-107I1 |
2513.62 | 182.04 | 189.59 |
oral squamous cell carcinoma cell line:HSC-3 | 10545-107H5 |
486.64 | 49.44 | 34.37 |
oral squamous cell carcinoma cell line:SAS | 10544-107H4 |
203.30 | 59.37 | 65.38 |
osteoclastoma cell line:Hs 706.T | 10704-109H2 |
174.91 | 30.57 | 24.40 |
osteosarcoma cell line:143B/TK^(-)neo^(R) | 10510-107D6 |
325.15 | 71.94 | 62.60 |
osteosarcoma cell line:HS-Os-1 | 10558-107I9 |
119.60 | 26.30 | 24.81 |
ovary, adult, pool1 | 10020-101D2 |
69.79 | 15.72 | 15.29 |
pagetoid sarcoma cell line:Hs 925.T | 10732-110B3 |
94.41 | 24.56 | 25.48 |
pancreas, adult, donor1 | 10049-101G4 |
73.37 | 22.58 | 19.75 |
pancreatic carcinoma cell line:NOR-P1 | 10698-109G5 |
88.89 | 10.90 | 11.46 |
papillary adenocarcinoma cell line:8505C | 10437-106E5 |
600.32 | 101.70 | 75.98 |
papillotubular adenocarcinoma cell line:TGBC18TKB | 10417-106C3 |
627.56 | 68.05 | 65.57 |
paracentral gyrus, adult, pool1 | 10035-101E8 |
44.57 | 25.63 | 18.30 |
parietal cortex, adult, donor10258 | 10373-105G4 |
20.55 | 21.29 | 19.08 |
parietal lobe - adult, donor10196 | 10171-103B9 |
42.32 | 19.75 | 22.57 |
parietal lobe, adult, donor10252 | 10157-103A4 |
14.25 | 19.67 | 16.82 |
parietal lobe, adult, pool1 | 10034-101E7 |
30.58 | 19.74 | 15.77 |
parietal lobe, fetal, donor1 | 10072-101I9 |
67.89 | 41.70 | 54.31 |
parietal lobe, newborn, donor10223 | 10356-105E5 |
109.54 | 32.90 | 26.54 |
parotid gland, adult | 10199-103F1 |
101.13 | 17.27 | 17.27 |
penis, adult | 10200-103F2 |
70.90 | 21.48 | 13.43 |
peripheral neuroectodermal tumor cell line:KU-SN | 10697-109G4 |
95.39 | 16.36 | 23.80 |
pharyngeal carcinoma cell line:Detroit 562 | 10723-110A3 |
453.84 | 24.33 | 23.75 |
pineal gland - adult, donor10196 | 10179-103C8 |
17.42 | 7.74 | 12.26 |
pineal gland, adult, donor10252 | 10160-103A7 |
11.25 | 13.03 | 15.40 |
pineal gland, adult, donor10258 | 10377-105G8 |
18.81 | 10.03 | 15.05 |
pituitary gland - adult, donor10196 | 10180-103C9 |
28.33 | 13.15 | 19.22 |
pituitary gland, adult, donor10252 | 10162-103A9 |
17.20 | 18.76 | 15.11 |
pituitary gland, adult, donor10258 | 10378-105G9 |
22.98 | 6.81 | 14.47 |
placenta, adult, pool1 | 10021-101D3 |
182.75 | 22.04 | 19.67 |
plasma cell leukemia cell line:ARH-77 | 10840-111E3 |
206.06 | 84.75 | 132.56 |
pleomorphic hepatocellular carcinoma cell line:SNU-387 | 10706-109H4 |
456.49 | 83.27 | 58.05 |
pons, adult, pool1 | 10033-101E6 |
139.95 | 27.11 | 17.04 |
postcentral gyrus, adult, pool1 | 10032-101E5 |
33.56 | 26.41 | 17.61 |
promyelocytes/myelocytes PMC, donor1 | 12132-128D8 |
12.55 | 4.18 | 2.09 |
promyelocytes/myelocytes PMC, donor2 | 12136-128E3 |
622.41 | 126.68 | 170.75 |
promyelocytes/myelocytes PMC, donor3 | 12140-128E7 |
657.20 | 140.83 | 82.15 |
prostate cancer cell line:DU145 | 10490-107B4 |
797.64 | 110.70 | 114.64 |
prostate cancer cell line:PC-3 | 10439-106E7 |
180.96 | 58.63 | 54.27 |
prostate, adult, pool1 | 10022-101D4 |
56.77 | 17.96 | 16.05 |
putamen, adult, donor10196 | 10176-103C5 |
31.40 | 29.98 | 21.72 |
putamen, adult, donor10252 | 10152-102I8 |
39.21 | 19.61 | 21.57 |
putamen, adult, donor10258, tech_rep1 | 10372-105G3 |
40.43 | 30.60 | 81.96 |
putamen, adult, donor10258, tech_rep2 | 10372-105G3 |
22.95 | 11.36 | 16.91 |
putamen, newborn, donor10223 | 10365-105F5 |
134.19 | 41.98 | 40.48 |
rectal cancer cell line:TT1TKB | 10469-106I1 |
166.41 | 21.24 | 18.04 |
rectum, fetal, donor1 | 10067-101I4 |
76.50 | 9.74 | 23.65 |
renal cell carcinoma cell line:OS-RC-2 | 10411-106B6 |
238.71 | 54.48 | 61.06 |
renal cell carcinoma cell line:TUHR10TKB | 10471-106I3 |
93.20 | 48.46 | 97.75 |
retina, adult, pool1 | 10030-101E3 |
35.39 | 10.74 | 8.95 |
retinoblastoma cell line:Y79 | 10475-106I7 |
94.31 | 102.10 | 93.79 |
rhabdomyosarcoma cell line:KYM-1 | 10787-110H4 |
151.23 | 51.76 | 52.74 |
rhabdomyosarcoma cell line:RMS-YM | 10477-106I9 |
50.90 | 28.96 | 29.24 |
sacrococcigeal teratoma cell line:HTST | 10695-109G2 |
286.47 | 18.19 | 21.98 |
salivary acinar cells, donor1 | 11771-123I7 |
181.28 | 26.87 | 23.47 |
salivary acinar cells, donor2 | 11772-123I8 |
166.60 | 21.89 | 13.36 |
salivary acinar cells, donor3 | 11773-123I9 |
39.06 | 9.27 | 4.63 |
salivary gland, adult, pool1 | 10093-102C3 |
144.70 | 18.30 | 32.60 |
schwannoma cell line:HS-PSS, tech_rep1 | 10442-106F1 |
163.56 | 32.88 | 24.62 |
schwannoma cell line:HS-PSS, tech_rep2 | 10442-106F1 |
167.28 | 40.44 | 29.27 |
seminal vesicle, adult | 10201-103F3 |
66.66 | 19.05 | 13.23 |
serous adenocarcinoma cell line:JHOS-2 | 10639-108I9 |
233.94 | 42.51 | 42.75 |
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1 | 11843-124H7 |
259.18 | 77.00 | 126.57 |
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1 | 11841-124H5 |
425.50 | 88.31 | 126.45 |
serous cystadenocarcinoma cell line:HTOA | 10693-109F9 |
103.70 | 13.03 | 9.67 |
signet ring carcinoma cell line:Kato III | 10436-106E4 |
1565.96 | 52.50 | 30.51 |
signet ring carcinoma cell line:NUGC-4 | 10483-107A6 |
1073.75 | 41.03 | 37.55 |
skeletal muscle - soleus muscle, donor1 | 10282-104F3 |
24.12 | 8.51 | 8.51 |
skeletal muscle, adult, pool1 | 10023-101D5 |
61.17 | 16.91 | 10.79 |
skeletal muscle, fetal, donor1 | 10066-101I3 |
32.16 | 8.04 | 12.06 |
skin, adult, donor1 | 10074-102A2 |
156.06 | 20.36 | 6.79 |
skin, fetal, donor1 | 10065-101I2 |
103.52 | 26.51 | 18.94 |
small cell cervical cancer cell line:HCSC-1 | 10800-110I8 |
221.79 | 73.04 | 103.73 |
small cell gastrointestinal carcinoma cell line:ECC10 | 10610-108F7 |
70.61 | 82.58 | 69.35 |
small cell lung carcinoma cell line:DMS 144 | 10841-111E4 |
30.26 | 29.88 | 60.72 |
small cell lung carcinoma cell line:LK-2 | 10541-107H1 |
900.62 | 158.23 | 120.65 |
small cell lung carcinoma cell line:NCI-H82 | 10842-111E5 |
9.81 | 19.95 | 57.91 |
small cell lung carcinoma cell line:WA-hT | 10562-108A4 |
97.84 | 27.02 | 27.24 |
small intestine, adult, pool1 | 10024-101D6 |
379.11 | 32.85 | 24.72 |
small intestine, fetal, donor1 | 10064-101I1 |
197.29 | 29.73 | 18.67 |
small-cell gastrointestinal carcinoma cell line:ECC4 | 10609-108F6 |
323.13 | 85.14 | 66.16 |
smooth muscle, adult, pool1 | 10048-101G3 |
58.41 | 26.36 | 24.55 |
somatostatinoma cell line:QGP-1 | 10781-110G7 |
90.86 | 31.09 | 28.68 |
spinal cord - adult, donor10196 | 10181-103D1 |
55.52 | 17.21 | 14.45 |
spinal cord, adult, donor10252 | 10159-103A6 |
53.23 | 26.81 | 16.95 |
spinal cord, adult, donor10258 | 10369-105F9 |
50.50 | 30.44 | 42.89 |
spinal cord, fetal, donor1 | 10056-101H2 |
78.06 | 28.66 | 20.73 |
spinal cord, newborn, donor10223 | 10359-105E8 |
154.30 | 26.63 | 27.55 |
spindle cell sarcoma cell line:Hs 132.T | 10737-110B8 |
134.57 | 26.44 | 23.60 |
spleen, adult, pool1 | 10025-101D7 |
71.48 | 17.62 | 20.60 |
spleen, fetal, pool1 | 10044-101F8 |
56.57 | 11.28 | 12.87 |
splenic lymphoma with villous lymphocytes cell line:SLVL | 10424-106D1 |
272.86 | 51.86 | 53.83 |
squamous cell carcinoma cell line:EC-GI-10 | 10463-106H4 |
627.16 | 63.23 | 69.68 |
squamous cell carcinoma cell line:JHUS-nk1 | 10646-109A7 |
145.37 | 30.75 | 24.81 |
squamous cell carcinoma cell line:T3M-5 | 10616-108G4 |
174.36 | 35.18 | 48.87 |
squamous cell lung carcinoma cell line:EBC-1 | 10486-107A9 |
856.91 | 48.63 | 23.98 |
squamous cell lung carcinoma cell line:LC-1F | 10457-106G7 |
1092.05 | 77.10 | 94.46 |
squamous cell lung carcinoma cell line:RERF-LC-AI | 10501-107C6 |
189.11 | 41.04 | 70.23 |
stomach, fetal, donor1 | 10062-101H8 |
164.47 | 27.77 | 18.16 |
submaxillary gland, adult | 10202-103F4 |
107.67 | 18.80 | 21.65 |
substantia nigra - adult, donor10196 | 10178-103C7 |
54.27 | 0.00 | 54.27 |
substantia nigra, adult, donor10252 | 10158-103A5 |
49.02 | 18.49 | 15.16 |
substantia nigra, adult, donor10258 | 10371-105G2 |
13.97 | 9.83 | 23.79 |
substantia nigra, newborn, donor10223 | 10358-105E7 |
108.11 | 12.01 | 24.02 |
synovial sarcoma cell line:HS-SY-II | 10441-106E9 |
250.82 | 53.88 | 47.23 |
temporal lobe, adult, pool1 | 10031-101E4 |
30.69 | 21.53 | 17.55 |
temporal lobe, fetal, donor1, tech_rep1 | 10063-101H9 |
58.41 | 38.46 | 40.60 |
temporal lobe, fetal, donor1, tech_rep2 | 10063-101H9 |
68.13 | 33.84 | 40.00 |
tenocyte, donor1 | 11763-123H8 |
224.12 | 41.89 | 37.00 |
tenocyte, donor2 | 11765-123I1 |
468.87 | 41.97 | 37.01 |
tenocyte, donor3 | 11768-123I4 |
379.56 | 44.85 | 36.70 |
teratocarcinoma cell line:NCC-IT-A3 | 10790-110H7 |
247.97 | 57.79 | 65.94 |
teratocarcinoma cell line:NCR-G1 | 10798-110I6 |
146.90 | 68.29 | 100.50 |
teratocarcinoma cell line:PA-1 | 10807-111A6 |
106.31 | 53.78 | 66.49 |
testicular germ cell embryonal carcinoma cell line:ITO-II | 10786-110H3 |
280.43 | 53.95 | 50.40 |
testicular germ cell embryonal carcinoma cell line:NEC14 | 10591-108D6 |
50.30 | 16.64 | 23.45 |
testicular germ cell embryonal carcinoma cell line:NEC15 | 10593-108D8 |
107.64 | 31.41 | 36.75 |
testicular germ cell embryonal carcinoma cell line:NEC8 | 10590-108D5 |
369.02 | 46.58 | 47.55 |
testis, adult, pool1 | 10026-101D8 |
51.32 | 16.32 | 14.92 |
testis, adult, pool2 | 10096-102C6 |
23.91 | 5.41 | 9.02 |
thalamus - adult, donor10196 | 10168-103B6 |
43.06 | 23.18 | 27.60 |
thalamus, adult, donor10252 | 10154-103A1 |
20.63 | 15.78 | 13.13 |
thalamus, adult, donor10258, tech_rep1 | 10370-105G1 |
35.41 | 10.78 | 40.03 |
thalamus, adult, donor10258, tech_rep2 | 10370-105G1 |
31.95 | 11.03 | 12.85 |
thalamus, newborn, donor10223 | 10366-105F6 |
258.32 | 50.63 | 40.27 |
throat, adult | 10209-103G2 |
758.00 | 24.47 | 16.48 |
throat, fetal, donor1 | 10061-101H7 |
68.25 | 15.54 | 12.49 |
thymic carcinoma cell line:Ty-82 | 10803-111A2 |
328.90 | 81.68 | 79.10 |
thymus, adult, pool1 | 10027-101D9 |
170.20 | 36.58 | 46.03 |
thymus, fetal, pool1 | 10043-101F7 |
125.10 | 25.25 | 30.76 |
thyroid carcinoma cell line:KHM-5M | 10776-110G2 |
522.40 | 85.89 | 91.88 |
thyroid carcinoma cell line:TCO-1 | 10783-110G9 |
252.98 | 95.13 | 101.14 |
thyroid, adult, pool1 | 10028-101E1 |
91.63 | 15.12 | 16.61 |
thyroid, fetal, donor1 | 10060-101H6 |
64.86 | 14.50 | 11.34 |
tongue epidermis (fungiform papillae), donor1 | 10288-104F9 |
89.31 | 6.16 | 6.16 |
tongue, adult | 10203-103F5 |
2304.38 | 30.24 | 20.23 |
tongue, fetal, donor1 | 10059-101H5 |
300.69 | 22.86 | 22.46 |
tonsil, adult, pool1 | 10047-101G2 |
553.57 | 23.94 | 16.53 |
trachea, adult, pool1 | 10029-101E2 |
319.59 | 35.01 | 22.66 |
trachea, fetal, donor1 | 10058-101H4 |
158.11 | 21.54 | 17.70 |
transitional cell carcinoma cell line:Hs 769.T | 10707-109H5 |
671.00 | 46.41 | 35.07 |
transitional-cell carcinoma cell line:5637 | 10418-106C4 |
434.65 | 89.36 | 62.11 |
transitional-cell carcinoma cell line:JMSU1 | 10492-107B6 |
300.37 | 71.14 | 79.28 |
tridermal teratoma cell line:HGRT | 10694-109G1 |
167.42 | 30.44 | 7.61 |
tubular adenocarcinoma cell line:SUIT-2 | 10797-110I5 |
174.21 | 18.96 | 19.89 |
umbilical cord, fetal, donor1 | 10057-101H3 |
54.25 | 8.35 | 10.43 |
uterus, adult, pool1 | 10100-102D1 |
82.24 | 13.14 | 18.09 |
uterus, fetal, donor1 | 10055-101H1 |
455.62 | 43.00 | 34.30 |
vagina, adult | 10204-103F6 |
31.66 | 8.40 | 18.09 |
vein, adult | 10191-103E2 |
49.98 | 9.21 | 12.49 |
xeroderma pigentosum b cell line:XPL 17 | 10563-108A5 |
177.05 | 40.86 | 53.41 |